Cover
Cover - USD ($) $ in Billions | 12 Months Ended | ||
Feb. 05, 2023 | Mar. 24, 2023 | Aug. 05, 2022 | |
Cover [Abstract] | |||
Document Type | 10-K | ||
Document Annual Report | true | ||
Document Period End Date | Feb. 05, 2023 | ||
Current Fiscal Year End Date | --02-05 | ||
Document Transition Report | false | ||
Entity File Number | 001-37570 | ||
Entity Registrant Name | Pure Storage, Inc. | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Tax Identification Number | 27-1069557 | ||
Entity Address, Address Line One | 650 Castro Street | ||
Entity Address, Address Line Two | Suite 400 | ||
Entity Address, City or Town | Mountain View | ||
Entity Address, State or Province | CA | ||
Entity Address, Postal Zip Code | 94041 | ||
City Area Code | 800 | ||
Local Phone Number | 379-7873 | ||
Title of 12(b) Security | Class A Common Stock, par value $0.0001 per share | ||
Trading Symbol | PSTG | ||
Security Exchange Name | NYSE | ||
Entity Well-Known Seasoned Issuer | Yes | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Large Accelerated Filer | ||
Entity Small Business | false | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | true | ||
Entity Shell Company | false | ||
Entity Public Float | $ 8.3 | ||
Entity Common Stock, Shares Outstanding (in shares) | 308,045,301 | ||
Documents Incorporated by Reference | Portions of the registrant’s proxy statement for its 2023 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Such proxy statement will be filed with the Securities and Exchange Commission within 120 days of the registrant’s fiscal year ended February 5, 2023. | ||
Amendment Flag | false | ||
Document Fiscal Year Focus | 2023 | ||
Document Fiscal Period Focus | FY | ||
Entity Central Index Key | 0001474432 |
Audit Information
Audit Information | 12 Months Ended |
Feb. 05, 2023 | |
Audit Information [Abstract] | |
Auditor Name | Deloitte & Touche LLP |
Auditor Location | San Jose, CA |
Auditor Firm ID | 34 |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Thousands | Feb. 05, 2023 | Feb. 06, 2022 |
Current assets: | ||
Cash and cash equivalents | $ 580,854 | $ 466,199 |
Marketable securities | 1,001,352 | 947,073 |
Accounts receivable, net of allowance of $945 and $1,057 | 612,491 | 542,144 |
Inventory | 50,152 | 38,942 |
Deferred commissions, current | 68,617 | 81,589 |
Prepaid expenses and other current assets | 161,391 | 116,232 |
Total current assets | 2,474,857 | 2,192,179 |
Property and equipment, net | 272,445 | 195,282 |
Operating lease right-of-use assets | 158,912 | 111,763 |
Deferred commissions, non-current | 177,239 | 164,718 |
Intangible assets, net | 49,222 | 62,646 |
Goodwill | 361,427 | 358,736 |
Restricted cash | 10,544 | 10,544 |
Other assets, non-current | 38,814 | 39,447 |
Total assets | 3,543,460 | 3,135,315 |
Current liabilities: | ||
Accounts payable | 67,121 | 70,704 |
Accrued compensation and benefits | 232,636 | 205,431 |
Accrued expenses and other liabilities | 123,749 | 78,511 |
Operating lease liabilities, current | 33,707 | 35,098 |
Deferred revenue, current | 718,149 | 562,576 |
Debt, current | 574,506 | 0 |
Total current liabilities | 1,749,868 | 952,320 |
Long-term debt | 0 | 786,779 |
Operating lease liabilities, non-current | 142,473 | 93,479 |
Deferred revenue, non-current | 667,501 | 517,296 |
Other liabilities, non-current | 42,385 | 31,105 |
Total liabilities | 2,602,227 | 2,380,979 |
Commitments and contingencies (Note 8) | ||
Stockholders’ equity: | ||
Preferred stock, par value of $0.0001 per share— 20,000 shares authorized; no shares issued and outstanding | 0 | 0 |
Class A and Class B common stock, par value of $0.0001 per share— 2,250,000 (Class A 2,000,000, Class B 250,000) shares authorized; 292,633 and 304,076 Class A shares issued and outstanding | 30 | 29 |
Additional paid-in capital | 2,493,769 | 2,470,943 |
Accumulated other comprehensive loss | (15,504) | (8,365) |
Accumulated deficit | (1,537,062) | (1,708,271) |
Total stockholders’ equity | 941,233 | 754,336 |
Total liabilities and stockholders’ equity | $ 3,543,460 | $ 3,135,315 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands | Feb. 05, 2023 | Feb. 06, 2022 |
Accounts receivable, allowance | $ 1,057 | $ 945 |
Preferred stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 |
Preferred stock, shares authorized (in shares) | 20,000,000 | 20,000,000 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Common stock, shares authorized (in shares) | 2,250,000,000 | 2,250,000,000 |
Class A common stock | ||
Common stock, shares authorized (in shares) | 2,000,000,000 | 2,000,000,000 |
Common stock, par value per share (in dollars per share) | $ 0.0001 | $ 0.0001 |
Common stock, shares issued (in shares) | 304,076,234 | 292,633,000 |
Common stock, shares outstanding (in shares) | 304,076,234 | 292,633,000 |
Class B common stock | ||
Common stock, shares authorized (in shares) | 250,000,000 | 250,000,000 |
Common stock, par value per share (in dollars per share) | $ 0.0001 | $ 0.0001 |
Consolidated Statements of Oper
Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
Feb. 05, 2023 | Feb. 06, 2022 | Jan. 31, 2021 | |
Revenue | $ 2,753,434 | $ 2,180,848 | $ 1,684,179 |
Cost of revenue | 855,788 | 708,329 | 535,255 |
Gross profit | 1,897,646 | 1,472,519 | 1,148,924 |
Operating expenses: | |||
Research and development | 692,528 | 581,935 | 480,467 |
Sales and marketing | 883,609 | 799,001 | 716,014 |
General and administrative | 237,996 | 189,981 | 182,477 |
Restructuring and other | 0 | 0 | 30,999 |
Total operating expenses | 1,814,133 | 1,570,917 | 1,409,957 |
Income (loss) from operations | 83,513 | (98,398) | (261,033) |
Other income (expense), net | 8,295 | (30,098) | (9,127) |
Income (loss) before provision for income taxes | 91,808 | (128,496) | (270,160) |
Provision for income taxes | 18,737 | 14,763 | 11,916 |
Net income (loss) | $ 73,071 | $ (143,259) | $ (282,076) |
Net income (loss) per share attributable to common stockholders, basic (in dollars per share) | $ 0.24 | $ (0.50) | $ (1.05) |
Net income (loss) per share attributable to common stockholders, diluted (in dollars per share) | $ 0.23 | $ (0.50) | $ (1.05) |
Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, basic (in shares) | 299,478 | 285,882 | 267,824 |
Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, diluted (in shares) | 339,184 | 285,882 | 267,824 |
Product | |||
Revenue | $ 1,792,153 | $ 1,442,338 | $ 1,144,098 |
Cost of revenue | 569,793 | 477,899 | 352,987 |
Subscription services | |||
Revenue | 961,281 | 738,510 | 540,081 |
Cost of revenue | $ 285,995 | $ 230,430 | $ 182,268 |
Consolidated Statements of Comp
Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands | 12 Months Ended | ||
Feb. 05, 2023 | Feb. 06, 2022 | Jan. 31, 2021 | |
Statement of Comprehensive Income [Abstract] | |||
Net income (loss) | $ 73,071 | $ (143,259) | $ (282,076) |
Other comprehensive income (loss), net of tax: | |||
Unrealized net gains (losses) on available-for-sale securities | (7,108) | (15,107) | 3,213 |
Reclassification adjustment for net gains on available-for-sale securities included in net income (loss) | (31) | (668) | (1,252) |
Change in unrealized net gains (losses) on available-for-sale securities | (7,139) | (15,775) | 1,961 |
Comprehensive income (loss) | $ 65,932 | $ (159,034) | $ (280,115) |
Consolidated Statements of Stoc
Consolidated Statements of Stockholders’ Equity - USD ($) shares in Thousands, $ in Thousands | Total | Cumulative-effect adjustment from adoption of ASU 2020-06 | Restricted Stock Units | Restricted Stock | Common Stock | Common Stock Restricted Stock Units | Common Stock Restricted Stock | Additional Paid-In Capital | Additional Paid-In Capital Cumulative-effect adjustment from adoption of ASU 2020-06 | Additional Paid-In Capital Restricted Stock Units | Accumulated Other Comprehensive Income (Loss) | Accumulated Deficit | Accumulated Deficit Cumulative-effect adjustment from adoption of ASU 2020-06 |
Beginning balance (in shares) at Feb. 02, 2020 | 264,008 | ||||||||||||
Beginning balance at Feb. 02, 2020 | $ 830,118 | $ 26 | $ 2,107,579 | $ 5,449 | $ (1,282,936) | ||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||
Issuance of common stock upon exercise of stock options (in shares) | 9,734 | ||||||||||||
Issuance of common stock upon exercise of stock options | 59,510 | $ 1 | 59,509 | ||||||||||
Stock-based compensation expense | 242,685 | 242,685 | |||||||||||
Vesting of restricted stock units (in shares) | 11,241 | ||||||||||||
Vesting of restricted stock units | $ 0 | $ 1 | $ (1) | ||||||||||
Cancellation and forfeiture of restricted stock (in shares) | (317) | ||||||||||||
Cancellation and forfeiture of restricted stock | $ 0 | ||||||||||||
Tax withholding on vesting of equity awards (in shares) | (490) | ||||||||||||
Tax withholding on vesting of equity awards | (8,258) | (8,258) | |||||||||||
Common stock issued under employee stock purchase plan (in shares) | 3,714 | ||||||||||||
Common stock issued under employee stock purchase plan | 32,439 | 32,439 | |||||||||||
Repurchase of common stock (in shares) | (9,527) | ||||||||||||
Repurchases of common stock | (135,175) | (135,175) | |||||||||||
Equity awards assumed in an acquisition | 8,802 | 8,802 | |||||||||||
Other comprehensive income (loss) | 1,961 | 1,961 | |||||||||||
Net income (loss) | (282,076) | (282,076) | |||||||||||
Ending balance (in shares) at Jan. 31, 2021 | 278,363 | ||||||||||||
Ending balance at Jan. 31, 2021 | 750,006 | $ 28 | 2,307,580 | 7,410 | (1,565,012) | ||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||
Issuance of common stock upon exercise of stock options (in shares) | 5,955 | ||||||||||||
Issuance of common stock upon exercise of stock options | 48,543 | 48,543 | |||||||||||
Stock-based compensation expense | 289,185 | 289,185 | |||||||||||
Vesting of restricted stock units (in shares) | 12,955 | ||||||||||||
Vesting of restricted stock units | 0 | $ 1 | (1) | ||||||||||
Cancellation and forfeiture of restricted stock (in shares) | (62) | ||||||||||||
Cancellation and forfeiture of restricted stock | $ 0 | ||||||||||||
Tax withholding on vesting of equity awards (in shares) | (454) | ||||||||||||
Tax withholding on vesting of equity awards | (10,835) | (10,835) | |||||||||||
Common stock issued under employee stock purchase plan (in shares) | 4,365 | ||||||||||||
Common stock issued under employee stock purchase plan | 36,641 | 36,641 | |||||||||||
Repurchase of common stock (in shares) | (8,489) | ||||||||||||
Repurchases of common stock | (200,170) | (200,170) | |||||||||||
Other comprehensive income (loss) | (15,775) | (15,775) | |||||||||||
Net income (loss) | (143,259) | (143,259) | |||||||||||
Ending balance (in shares) at Feb. 06, 2022 | 292,633 | ||||||||||||
Ending balance at Feb. 06, 2022 | $ 754,336 | $ (35,127) | $ 29 | 2,470,943 | $ (133,265) | (8,365) | (1,708,271) | $ 98,138 | |||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||||||
Accounting Standards Update [Extensible Enumeration] | Accounting Standards Update 2020-06 [Member] | ||||||||||||
Issuance of common stock upon exercise of stock options (in shares) | 2,988 | ||||||||||||
Issuance of common stock upon exercise of stock options | $ 25,073 | 25,073 | |||||||||||
Stock-based compensation expense | 329,723 | 329,723 | |||||||||||
Vesting of restricted stock units (in shares) | 13,916 | ||||||||||||
Vesting of restricted stock units | $ 0 | $ 1 | $ (1) | ||||||||||
Tax withholding on vesting of equity awards (in shares) | (643) | ||||||||||||
Tax withholding on vesting of equity awards | (19,601) | (19,601) | |||||||||||
Common stock issued under employee stock purchase plan (in shares) | 3,014 | ||||||||||||
Common stock issued under employee stock purchase plan | 39,966 | 39,965 | |||||||||||
Repurchase of common stock (in shares) | (7,832) | ||||||||||||
Repurchases of common stock | (219,069) | (219,068) | |||||||||||
Other comprehensive income (loss) | (7,139) | (7,139) | |||||||||||
Net income (loss) | 73,071 | 73,071 | |||||||||||
Ending balance (in shares) at Feb. 05, 2023 | 304,076 | ||||||||||||
Ending balance at Feb. 05, 2023 | $ 941,233 | $ 30 | $ 2,493,769 | $ (15,504) | $ (1,537,062) |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 12 Months Ended | ||
Feb. 05, 2023 | Feb. 06, 2022 | Jan. 31, 2021 | |
CASH FLOWS FROM OPERATING ACTIVITIES | |||
Net income (loss) | $ 73,071 | $ (143,259) | $ (282,076) |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||
Depreciation and amortization | 100,432 | 83,151 | 70,042 |
Amortization of debt discount and debt issuance costs | 3,210 | 31,577 | 29,070 |
Stock-based compensation expense | 327,617 | 286,963 | 242,344 |
Impairment of long-lived assets | 0 | 471 | 7,505 |
Other | 4,145 | 13,075 | 7,340 |
Changes in operating assets and liabilities, net of effects of acquisitions: | |||
Accounts receivable, net | (70,724) | (81,247) | 410 |
Inventory | (10,619) | 4,118 | (8,690) |
Deferred commissions | 451 | (58,383) | (48,721) |
Prepaid expenses and other assets | (31,580) | (25,788) | (33,982) |
Operating lease right-of-use assets | 33,813 | 29,952 | 28,804 |
Accounts payable | (7,075) | 6,711 | (14,364) |
Accrued compensation and other liabilities | 72,084 | 58,961 | 76,972 |
Operating lease liabilities | (33,359) | (32,351) | (27,318) |
Deferred revenue | 305,768 | 236,176 | 140,305 |
Net cash provided by operating activities | 767,234 | 410,127 | 187,641 |
CASH FLOWS FROM INVESTING ACTIVITIES | |||
Purchases of property and equipment | (158,139) | (102,287) | (94,975) |
Acquisitions, net of cash acquired | (1,989) | 0 | (339,641) |
Purchases of marketable securities | (501,435) | (617,043) | (573,959) |
Sales of marketable securities | 6,155 | 200,482 | 171,530 |
Maturities of marketable securities | 433,995 | 366,165 | 423,936 |
Other | 0 | (600) | (5,000) |
Net cash used in investing activities | (221,413) | (153,283) | (418,109) |
CASH FLOWS FROM FINANCING ACTIVITIES | |||
Net proceeds from exercise of stock options | 24,778 | 48,709 | 59,339 |
Proceeds from issuance of common stock under employee stock purchase plan | 39,965 | 36,641 | 32,439 |
Proceeds from borrowings, net of issuance costs | 0 | 0 | 251,892 |
Principal payments on borrowings and finance lease obligations | (257,240) | (2,137) | 0 |
Tax withholding on vesting of equity awards | (19,601) | (10,835) | (8,258) |
Repurchases of common stock | (219,068) | (200,170) | (135,175) |
Net cash provided by (used in) financing activities | (431,166) | (127,792) | 200,237 |
Net increase (decrease) in cash, cash equivalents and restricted cash | 114,655 | 129,052 | (30,231) |
Cash, cash equivalents and restricted cash, beginning of year | 476,743 | 347,691 | 377,922 |
Cash, cash equivalents and restricted cash, end of year | 591,398 | 476,743 | 347,691 |
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT END OF YEAR | |||
Cash and cash equivalents | 466,199 | 337,147 | |
Restricted cash | 10,544 | 10,544 | 10,544 |
Cash, cash equivalents and restricted cash, end of year | 591,398 | 476,743 | 347,691 |
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION | |||
Cash paid for interest | 1,185 | 5,019 | 2,279 |
Cash paid for income taxes | 14,391 | 12,662 | 10,522 |
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING INFORMATION | |||
Property and equipment purchased but not yet paid | 14,902 | 7,441 | 10,979 |
Fair value of equity awards assumed in an acquisition | $ 0 | $ 0 | $ 8,802 |
Business Overview
Business Overview | 12 Months Ended |
Feb. 05, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Business Overview | Business Overview Organization and Description of Business Pure Storage, Inc. (the Company, we, us, or other similar pronouns) was originally incorporated in the state of Delaware in October 2009 under the name OS76, Inc. In January 2010, we changed our name to Pure Storage, Inc. We are headquartered in Mountain View, California and have wholly owned subsidiaries throughout the world. |
Basis of Presentation and Summa
Basis of Presentation and Summary of Significant Accounting Policies | 12 Months Ended |
Feb. 05, 2023 | |
Accounting Policies [Abstract] | |
Basis of Presentation and Summary of Significant Accounting Policies | Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation and Principles of Consolidation We operate using a 52/53 week fiscal year ending on the first Sunday after January 30. Fiscal 2021 and 2023 were both 52-week years that ended on January 31, 2021 and February 5, 2023, respectively. Fiscal 2022 was a 53-week year that ended on February 6, 2022. Unless otherwise stated, all dates refer to our fiscal years. The consolidated financial statements include the accounts of the Company and our wholly owned subsidiaries and have been prepared in conformity with accounting principles generally accepted in the United States (U.S. GAAP). All intercompany balances and transactions have been eliminated in consolidation. Foreign Currency The functional currency of our foreign subsidiaries is the U.S. dollar. Transactions denominated in currencies other than the functional currency are remeasured to the functional currency at the average exchange rate in effect during the period. At the end of each reporting period, monetary assets and liabilities are remeasured using exchange rates in effect at the balance sheet date. Non-monetary assets and liabilities are remeasured at historical exchange rates. Foreign currency transaction gains and losses are recorded in other income (expense), net in the consolidated statements of operations. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and accompanying notes. Actual results could differ from these estimates and assumptions due to risks and uncertainties. Such estimates include, but are not limited to, the determination of standalone selling price for revenue arrangements with multiple performance obligations when the price at which the performance obligation sold separately or observable past transactions are not available, useful lives of intangible assets and property and equipment, the period of benefit for deferred contract costs for commissions, stock-based compensation, provision for income taxes including related reserves, fair value of equity assumed, intangible and tangible assets acquired and liabilities assumed for business combinations. Management bases its estimates on historical experience and on various other assumptions which management believes to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Concentration Risk Financial instruments that are exposed to concentration of credit risk consist primarily of cash and cash equivalents, marketable securities, and accounts receivable. At the end of fiscal 2022 and 2023, the majority of our cash and cash equivalents are primarily invested with two global financial institutions and our deposits exceed federally insured limits. These two global financial institutions were identified by the Financial Stability Board in 2022 as being global systemically important banks and are allocated to buckets 2 or higher. Our investments are intended to facilitate liquidity and capital preservation and consist predominantly of highly-rated fixed income securities. Our investment policy also requires diversification of investment type and credit exposures, and includes certain limits on portfolio duration. Management believes that the financial institutions that hold our cash, cash equivalents and marketable securities are financially sound and, accordingly, are subject to minimal credit risk. We define a customer as an entity that purchases our products and services from one of our channel partners or from us directly. A substantial amount of our revenue and accounts receivable are derived from the United States across a multitude of industries. We perform ongoing evaluations to determine partner and customer credit. One channel partner represented 10 percent or more of total accounts receivable at the end of fiscal 2022. No customer or channel partner represented 10 percent or more of total accounts receivable at the end of fiscal 2023 or more than 10 percent of revenue for fiscal 2021, 2022 or 2023. We rely on a limited number of contract manufacturers and suppliers of components for our products. In instances where contract manufacturers and suppliers fail to perform their obligations, we may be unable to find alternative contract manufacturers and suppliers or satisfactorily deliver our products to our customers on time. Cash and Cash Equivalents Cash and cash equivalents consist of cash in banks and highly liquid investments, primarily money market accounts and U.S. government treasury notes, purchased with an original maturity of three months or less. Marketable Securities We classify our marketable securities as available-for-sale (AFS) at the time of purchase and reevaluate such classification at each balance sheet date. We may sell these securities at any time for use in current operations even if they have not yet reached maturity. As a result, we classify our securities, including those with maturities beyond twelve months, as current assets in the consolidated balance sheets. We carry these securities at estimated fair value and record unrealized gains and losses in accumulated other comprehensive income (loss), which is reflected as a component of stockholders' equity. We evaluate our AFS debt securities with an unamortized cost basis in excess of estimated fair value to determine what amount of that difference, if any, is caused by expected credit losses. Credit-related impairment losses, not to exceed the amount that fair value is less than the amortized cost basis, are recognized through an allowance for credit losses with changes in the allowance for credit losses recognized as a charge to other income (expense), net, in the consolidated statements of operations. Any remaining impairment is included in accumulated other comprehensive income (loss) as a component of stockholders' equity. Realized gains and losses from the sale of marketable securities are determined based on the specific identification method. Realized gains and losses are reported in other income (expense), net in the consolidated statements of operations. Fair Value of Financial Instruments The carrying value of our financial instruments, including cash equivalents, accounts receivable, accounts payable and accrued liabilities, approximates fair value. Accounts Receivable and Allowance Accounts receivable are recorded at the invoiced amount, and stated at realizable value, net of an allowance for doubtful accounts. Credit is extended to partners and customers based on an evaluation of their financial condition and other factors. We generally do not require collateral or other security to support accounts receivable. We perform ongoing credit evaluations and maintain an allowance for doubtful accounts. We assess the collectability of the accounts by taking into consideration the aging of our trade receivables, historical experience, and management judgment. We write off trade receivables against the allowance when management determines a balance is uncollectible and no longer actively pursues collection of the receivable. The following table presents the changes in the allowance for doubtful accounts: Fiscal Year Ended 2021 2022 2023 (in thousands) Allowance for doubtful accounts, beginning balance $ 542 $ 1,033 $ 945 Provision, net of cash received 496 (18) 377 Write-offs (5) (70) (265) Allowance for doubtful accounts, ending balance $ 1,033 $ 945 $ 1,057 Restricted Cash Restricted cash is comprised of cash collateral for letters of credit related to our leases and for a vendor credit card program. At the end of fiscal 2022 and 2023, we had restricted cash of $10.5 million. Inventory Inventory consists of finished goods and component parts, which are purchased from contract manufacturers. Product demonstration units, which we regularly sell, are the primary component of our inventories. Inventories are stated at the lower of cost or net realizable value. Cost is determined using the specific identification method for finished goods and weighted-average method for component parts. We account for excess and obsolete inventory by reducing the carrying value to the estimated net realizable value of the inventory based upon management’s assumptions about future demand and market conditions. In addition, we record a liability for firm, non-cancelable and unconditional purchase commitments with contract manufacturers and suppliers for quantities in excess of future demand forecasts consistent with excess and obsolete inventory valuations. Inventory write-offs were insignificant for fiscal 2021, 2022 and 2023. Property and Equipment, Net Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation and amortization is computed using the straight-line method over the estimated useful lives of the respective assets (test equipment—4 years, computer equipment and software—4 to 5 years, furniture and fixtures—7 years). Leasehold improvements are amortized over the shorter of their estimated useful lives or the remaining lease term. Depreciation commences once the asset is placed in service. In accordance with our accounting practices, we review the estimated useful lives of our property and equipment on an ongoing basis. In the first quarter of fiscal 2021, management determined that the estimated useful lives of its test equipment and certain computer equipment and software required revision. The estimated useful lives of test equipment and certain computer equipment and software were revised to 4 years. Previously, the estimated useful lives of these assets ranged from 2 to 3 years. The change in estimated useful lives was accounted for as a change in estimate and recognized on a prospective basis effective February 3, 2020. The effect of this change in estimate resulted in a reduction to depreciation expense of $23.6 million during fiscal 2021. Business Combinations We allocate the purchase price to the assets acquired and liabilities assumed based on their estimated fair values. The excess of the purchase price over the fair values of the assets acquired and liabilities assumed is recorded as goodwill. During the measurement period, which may be up to one year from the acquisition date, we may record adjustments to the estimated fair value of the assets acquired and liabilities assumed, with the corresponding offset to goodwill. The results of operations of an acquired business is included in our consolidated financial statements from the date of acquisition. Acquisition-related expenses are expensed as incurred. Goodwill Goodwill represents the excess of the purchase price consideration over the estimated fair value of the tangible and intangible assets acquired and liabilities assumed in a business combination. Goodwill is evaluated for impairment annually in the fourth quarter of our fiscal year as a single reporting unit, and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. We may elect to qualitatively assess whether it is more likely than not that the fair value of our reporting unit is less than its carrying value. If we opt not to qualitatively assess, a quantitative goodwill impairment test is performed. The quantitative test compares our reporting unit's carrying amount, including goodwill, to its fair value calculated based on our enterprise value. If the carrying amount exceeds its fair value, an impairment loss is recognized for the excess. Purchased Intangible Assets Purchased intangible assets with finite lives are stated at cost, net of accumulated amortization. We amortize our intangible assets on a straight-line basis over an estimated useful life of three Impairment of Long-Lived Assets We review our long-lived assets, including property and equipment and finite-lived intangible assets, for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. We measure the recoverability of these assets by comparing the carrying amounts to the future undiscounted cash flows the assets are expected to generate. If the total of the future undiscounted cash flows is less than the carrying amount of an asset, we record an impairment charge for the amount by which the carrying amount of the asset exceeds its fair value. Convertible Senior Notes Prior to the adoption of Accounting Standards Update (ASU) 2020-06 on February 7, 2022, in accounting for the issuance of our convertible senior notes (the Notes), we separated the Notes into liability and equity components. The carrying amount of the liability component was determined by measuring the fair value of a similar debt instrument that does not have an associated convertible feature. The carrying amount of the equity component representing the conversion option was calculated by deducting the fair value of the liability component from the principal amount of the Notes as a whole. This difference represented a debt discount that was amortized to interest expense using the effective interest method over the term of the Notes. The equity component of the Notes was included in additional paid-in capital in the consolidated balance sheets and was not remeasured as it continued to meet the conditions for equity classification. Transaction costs related to the issuance of the Notes (debt issuance costs) were allocated to the liability and equity components using the same proportions as the initial carrying value of the Notes. The debt issuance costs attributable to the liability component were netted with the principal amount of the Notes and amortized to interest expense using the effective interest method over the term of the Notes. The debt issuance costs attributable to the equity component were netted with the equity component of the Notes in additional paid-in capital. Upon adoption of ASU 2020-06, we combined the liability and equity components assuming that the instrument was accounted for as a single liability from inception to the date of adoption, resulting in the elimination of the debt discount. Similarly, the liability and equity components of the debt issuance costs were combined as a reduction to the Notes and is being amortized to interest expense using the effective interest method over the remaining term of the Notes. Deferred Commissions Deferred commissions consist of incremental costs paid to our sales force to obtain customer contracts. Deferred commissions related to product revenue are recognized upon transfer of control to customers and deferred commissions related to subscription services revenue are amortized over an expected useful life of six years. We determine the expected useful life based on an estimated benefit period by evaluating our technology development life cycle, expected customer relationship period and other factors. We classify deferred commissions as current and non-current on our consolidated balance sheets based on the timing of when we expect to recognize the expense. Amortization of deferred commissions is included in sales and marketing expense in the consolidated statements of operations. Leases We determine if an arrangement contains a lease at inception and classify leases as an operating or finance lease at commencement date. Lease liabilities are recognized at the present value of the future lease payments at commencement date. The interest rate implicit in our operating and finance leases is not readily determinable, and therefore an incremental borrowing rate is estimated to determine the present value of future payments. The estimated incremental borrowing rate factors in a hypothetical interest rate on a collateralized basis with similar terms, payments, and economic environments. The lease right-of-use (ROU) asset is determined based on the lease liability initially established and reduced for any prepaid lease payments and any lease incentives. We account for the lease and non-lease components of operating and finance lease contract consideration as a single lease component. Certain of the operating lease agreements contain rent concession, rent escalation, and option to renew provisions. Rent concession and rent escalation provisions are considered in determining the lease cost. Lease cost under our operating leases is recognized on a straight-line basis over the lease term commencing on the date we have the right to use the leased property. For finance leases, we recognize amortization expense of the finance lease ROU asset on a straight-line basis over the shorter of its useful life or lease term and record interest expense for finance lease liabilities based on the incremental borrowing rate. We generally use the base, non-cancelable, lease term when recognizing the lease assets and liabilities, unless it is reasonably certain that an extension or termination option will be exercised. Assets recognized and the short and long-term lease liabilities from finance leases are included in property and equipment, net, accrued expenses and other liabilities and other liabilities, non-current in the consolidated balance sheets. In addition, certain of our operating lease agreements contain tenant improvement allowances from our landlords. These allowances are accounted for as lease incentives and reduce our ROU asset and lease cost over the lease term. For short-term leases (defined as leases that, at the commencement date, have a lease term of twelve months or less, and do not include an option to purchase the underlying asset that we are reasonably certain to exercise), we recognize rent expense in our consolidated statements of operations on a straight-line basis over the lease term and record variable lease payments as incurred. Deferred Revenue Deferred revenue primarily consists of amounts that have been invoiced but have not yet been recognized as revenue and performance obligations pertaining to subscription services. The current portion of deferred revenue represents the amounts that are expected to be recognized as revenue within one year of the consolidated balance sheet dates. Revenue Recognition We generate revenue from two sources: (1) product revenue which includes the sale of integrated storage hardware and embedded licensed operating system software and (2) subscription services revenue which includes our portfolio of Evergreen offerings and Portworx . Subscription services revenue also include our professional services offerings such as installation and implementation consulting services. We typically recognize product revenue upon transfer of control to our customers and the satisfaction of our performance obligations. For Evergreen//Flex , product revenue is recognized upon the commencement of the underlying subscription services. Products are typically shipped directly by us to customers. Our subscription services revenue is derived from the services we perform in connection with the sale of subscription services and is recognized ratably over the contractual term, which generally ranges from one Evergreen subscription service agreement, which typically commences upon transfer of control of the corresponding products to our customers. Costs for subscription services are expensed when incurred. In addition, our Evergreen subscription provides our customers with a new controller based upon certain contractual terms. The controller refresh represents a separate performance obligation that is included within the Evergreen subscription service agreement and the allocated revenue is recognized upon shipment of the controller . Our Evergreen subscription services also include the right to receive unspecified software updates and upgrades on a when-and-if-available basis, software bug fixes, replacement parts and other services related to the underlying infrastructure, as well as access to our cloud-based management and support platform. We also sell professional services such as installation and implementation consulting services and the related revenue is recognized as services are performed. We recognize revenue upon the transfer of promised goods or services to customers in an amount that reflects the consideration we expect to be entitled in exchange for those goods or services. This is achieved through applying the following five-step approach: • Identification of the contract, or contracts, with a customer • Identification of the performance obligations in the contract • Determination of the transaction price • Allocation of the transaction price to the performance obligations in the contract • Recognition of revenue when, or as, we satisfy a performance obligation When applying this five-step approach, we apply judgment in determining the customer's ability and intention to pay, which is based on a variety of factors including the customer's historical payment experience and/or published credit and financial information pertaining to the customer. To the extent a customer contract includes multiple promised goods or services, we determine whether promised goods or services should be accounted for as a separate performance obligation. The transaction price is determined based on the consideration which we will be entitled to in exchange for transferring goods or services to the customer. For contracts that contain multiple performance obligations, we allocate the transaction price to each performance obligation based on a relative standalone selling price (SSP). The SSP is determined based on the price at which the performance obligation is sold separately, or if not observable through past transactions, is estimated taking into account available information such as market conditions and internally approved pricing guidelines related to performance obligations. Warranty We generally provide a three-year warranty on hardware and a 90-day warranty on our software embedded in the hardware. Our hardware warranty provides for parts replacement for defective components and our software warranty provides for bug fixes. Our Evergreen subscription agreement provides for the same parts replacement that customers are entitled to under our warranty program, except that replacement parts are delivered according to targeted response times to minimize disruption to our customers’ critical business applications. Substantially all customers purchase Evergreen subscription agreements. We will establish a warranty reserve for specifically identified products if and when we determine we have systemic product failure. Our estimate for future estimated costs related to warranty activities is based upon historical product failure rates and historical costs incurred in correcting product failures. Warranty reserve at the end of fiscal 2023 was $7.4 million. Research and Development Research and development costs are expensed as incurred. Research and development costs consist primarily of employee compensation and related expenses, prototype expenses, to the extent there is no alternative use for that equipment, depreciation of equipment used in research and development, third-party engineering and contractor support costs, data center and cloud services costs as well as allocated overhead costs. Capitalized Internal-Use Software Costs We expense costs to develop software that is externally marketed before technological feasibility is reached. We have determined that technological feasibility is reached shortly before the release of our products and as a result, the development costs incurred after the establishment of technological feasibility and before the release of those products have not been significant and accordingly, all related software development costs have been expensed as incurred. We capitalize (i) costs incurred to develop or modify software solely for our internal use, including hosted applications used to deliver our support services, and (ii) certain implementation costs incurred in a hosting arrangement that is a service contract when the preliminary project stage is complete, management with the relevant authority authorizes and commits to the funding of the software project, and it is probable the project will be completed and used to perform the intended function. Costs related to preliminary project activities and post implementation activities are expensed as incurred. Software development costs are capitalized to property, plant and equipment and amortized using the straight-line method over an estimated useful life of four years. Software development costs capitalized to property and equipment were $7.8 million and $7.3 million for fiscal 2022 and 2023. Amortization expense for software development costs was none during fiscal 2021 and 2022 and $2.2 million during fiscal 2023. Software implementation costs are capitalized to either prepaid and other current assets or other assets, non-current on our consolidated balance sheet and amortized over the terms of the associated hosting arrangements. Software implementation costs capitalized were $3.5 million and $9.3 million for fiscal 2022 and 2023. Amortization expense for software implementation costs was $0.1 million, $0.5 million and $1.5 million during fiscal 2021, 2022 and 2023. Advertising Expenses Advertising costs are expensed as incurred. Advertising expenses were $8.1 million, $15.3 million and $11.1 million for fiscal 2021, 2022 and 2023. Stock-Based Compensation Stock-based compensation includes expenses related to restricted stock units (RSUs), performance restricted stock units (PRSUs), restricted stock, stock options and purchase rights issued to employees under our employee stock purchase plan (ESPP). RSUs, PRSUs and restricted stock are measured at the fair market value of the underlying stock at the grant date. We determine the fair value of purchase rights issued to employees under our ESPP and our stock options under our equity plans on the date of grant utilizing the Black-Scholes option pricing model, which is impacted by the fair value of our common stock, as well as changes in assumptions regarding a number of subjective variables. These variables include the expected common stock price volatility over the term of the awards, the expected term of the awards, risk-free interest rates and expected dividend yield. We recognize stock-based compensation expense for stock-based awards with only service conditions on a straight-line basis over the period during which an employee is required to provide services in exchange for the award (generally the vesting period of the award). We account for forfeitures as they occur. For stock-based awards granted to employees with a performance condition, we recognize stock-based compensation expense for these awards under the accelerated attribution method over the requisite service period when management determines it is probable that the performance condition will be satisfied. Income Taxes We account for income taxes using the asset and liability method. Deferred income taxes are recognized by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The measurement of deferred tax assets is reduced, if necessary, by a valuation allowance to amounts that are more likely than not to be realized. We recognize tax benefits from uncertain tax positions only if we believe that it is more likely than not that the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized in the financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. Recently Adopted Accounting Pronouncement In August 2020, the FASB issued ASU 2020-06, A ccounting for Convertible Instruments and Contracts in an Entity's Own Equity , which simplifies the accounting for certain convertible instruments, amends guidance on derivative scope exceptions for contracts in an entity's own equity, and requires the use of the if-converted method to calculate the impact of convertible instruments on diluted earnings per share (EPS) which results in the inclusion of the effect of share settlement for instruments that may be settled in cash or shares. We adopted this standard as of February 7, 2022 using the modified retrospective basis, under which financial results reported in prior periods were not adjusted. Adoption resulted in an adjustment of $133.3 million to reclassify the remaining balance of the conversion feature recorded in additional paid-in capital to the Notes of $35.2 million and accumulated deficit of $98.1 million on the consolidated balance sheet. Accordingly, we no longer carry an equity component of the Notes. For further information, see Note 7, Debt, and Note 13, Net Income (Loss) per Share Attributable to Common Stockholders. Recent Accounting Pronouncements |
Financial Instruments
Financial Instruments | 12 Months Ended |
Feb. 05, 2023 | |
Investments, Debt and Equity Securities [Abstract] | |
Financial Instruments | Financial Instruments Fair Value Measurements We define fair value as the exchange price that would be received from sale of an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. We measure our financial assets and liabilities at fair value at each reporting period using a fair value hierarchy which requires us to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Three levels of inputs may be used to measure fair value: • Level 1 - Observable inputs are unadjusted quoted prices in active markets for identical assets or liabilities; • Level 2 - Observable inputs are quoted prices for similar assets and liabilities in active markets or inputs other than quoted prices that are observable for the assets or liabilities, either directly or indirectly through market corroboration, for substantially the full term of the financial instruments; and • Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. These inputs are based on our own assumptions used to measure assets and liabilities at fair value and require significant management judgment or estimation. Cash Equivalents, Marketable Securities and Restricted Cash We measure our cash equivalents, marketable securities and restricted cash at fair value on a recurring basis. We classify our cash equivalents, marketable securities and restricted cash within Level 1 or Level 2 because they are valued using either quoted market prices or inputs other than quoted prices which are directly or indirectly observable in the market, including readily-available pricing sources for the identical underlying security which may not be actively traded. Our fixed income available-for-sale securities consist of high quality, investment grade securities from diverse issuers. The valuation techniques used to measure the fair value of our marketable securities were derived from non-binding market consensus prices that are corroborated by observable market data or quoted market prices for similar instruments. The following tables summarize our cash equivalents, marketable securities and restricted cash by significant investment categories and their classification within the fair value hierarchy at the end of fiscal 2022 and 2023 (in thousands): At the End of Fiscal 2022 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Cash Equivalents Marketable Securities Restricted Cash Level 1 Money market accounts $ — $ — $ — $ 29,275 $ 18,731 $ — $ 10,544 Level 2 U.S. government treasury notes 336,303 512 (2,176) 334,639 — 334,639 — U.S. government agencies 49,153 49 (193) 49,009 — 49,009 — Corporate debt securities 491,728 384 (4,731) 487,381 200 487,181 — Foreign government bonds 12,333 37 (17) 12,353 — 12,353 — Asset-backed securities 60,361 111 (453) 60,019 — 60,019 — Municipal bonds 3,950 — (78) 3,872 — 3,872 — Total $ 953,828 $ 1,093 $ (7,648) $ 976,548 $ 18,931 $ 947,073 $ 10,544 At the End of Fiscal 2023 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Cash Equivalents Marketable Securities Restricted Cash Level 1 Money market accounts $ — $ — $ — $ 49,733 $ 39,189 $ — $ 10,544 Level 2 U.S. government treasury notes 425,977 170 (4,229) 421,918 32,008 389,910 — U.S. government agencies 23,795 — (289) 23,506 — 23,506 — Corporate debt securities 527,164 901 (9,300) 518,765 — 518,765 — Foreign government bonds 4,797 — (44) 4,753 — 4,753 — Asset-backed securities 61,371 281 (1,016) 60,636 — 60,636 — Municipal bonds 3,950 — (168) 3,782 — 3,782 — Total $ 1,047,054 $ 1,352 $ (15,046) $ 1,083,093 $ 71,197 $ 1,001,352 $ 10,544 The amortized cost and estimated fair value of our marketable securities are shown below by contractual maturity (in thousands): At the End of Fiscal 2023 Amortized Cost Fair Value Due within one year $ 542,675 $ 537,272 Due in one to five years 468,427 460,091 Due in five to ten years 3,944 3,989 Total $ 1,015,046 $ 1,001,352 Unrealized losses on our debt securities have not been recorded into income because we do not intend to sell nor is it more likely than not that we will be required to sell these investments prior to recovery of their amortized cost basis. The decline in fair value of our debt securities is largely due to the rising interest rate environment driven by current market conditions that has resulted in higher credit spreads. The credit ratings associated with our debt securities are mostly unchanged, are highly rated and the issuers continue to make timely principal and interest payments. As a result, there were no credit or non-credit impairment charges recorded in fiscal 2021, 2022, and 2023. The following table presents gross unrealized losses and fair values for those investments that were in a continuous unrealized loss position at the end of fiscal 2022 and 2023, aggregated by investment category (in thousands): At the End of Fiscal 2022 Less than 12 months Greater than 12 months Total Fair Value Unrealized Loss Fair Value Unrealized Loss Fair Value Unrealized Loss U.S. government treasury notes $ 193,359 $ (2,176) $ — $ — $ 193,359 $ (2,176) U.S. government agencies 24,388 (193) — — 24,388 (193) Corporate debt securities 374,223 (4,708) 1,182 (23) 375,405 (4,731) Foreign government bonds 4,098 (17) — — 4,098 (17) Asset-backed securities 37,608 (453) — — 37,608 (453) Municipal bonds 3,872 (78) — — 3,872 (78) Total $ 637,548 $ (7,625) $ 1,182 $ (23) $ 638,730 $ (7,648) At the End of Fiscal 2023 Less than 12 months Greater than 12 months Total Fair Value Unrealized Loss Fair Value Unrealized Loss Fair Value Unrealized Loss U.S. government treasury notes $ 250,046 $ (130) $ 127,976 $ (4,099) $ 378,022 $ (4,229) U.S. government agencies 5,194 (5) 18,312 (284) 23,506 (289) Corporate debt securities 99,446 (330) 277,717 (8,970) 377,163 (9,300) Foreign government bonds 3,200 (5) 551 (39) 3,751 (44) Asset-backed securities 3,060 (25) 22,221 (991) 25,281 (1,016) Municipal bonds — — 3,782 (168) 3,782 (168) Total $ 360,946 $ (495) $ 450,559 $ (14,551) $ 811,505 $ (15,046) Realized gains or losses on sale of marketable securities were not significant for all periods presented. Other Financial Instruments We measure the fair value of our Notes on a quarterly basis and we determined the fair value of the Notes at the end of fiscal 2022 and 2023 to be a Level 2 measurement due to its limited trading activity. Refer to Note 7 for the net carrying amounts and estimated fair value of the Notes at the end of fiscal 2022 and 2023. |
Business Combination
Business Combination | 12 Months Ended |
Feb. 05, 2023 | |
Business Combination and Asset Acquisition [Abstract] | |
Business Combination | Business Combination In October 2020, we acquired all outstanding stock of Portworx Inc. (Portworx), a privately-held container storage company that provides a Kubernetes data services platform for cloud native applications. The transaction costs associated with the acquisition were not material and expensed as incurred. The total purchase consideration for the acquisition of Portworx was $352.9 million, which consisted of the following (in thousands): Cash $ 344,049 Fair value of options assumed 8,802 Total $ 352,851 We assumed certain unvested and outstanding stock options for Portworx's common stock. These stock options were converted into 1.9 million stock options for shares of our common stock. The fair value of the exchanged options determined using the Black-Scholes option pricing model was $26.8 million, of which $8.8 million attributable to services performed prior to the acquisition date was allocated to purchase consideration. The remaining fair value of $18.0 million was allocated to future services and is being expensed over the remaining service periods as stock-based compensation expense. In addition, we assumed 2.0 million RSUs outstanding with a fair value of $31.8 million that is being recognized as stock-based compensation expense over a four year vesting period. The following table summarizes the fair values of assets acquired and liabilities assumed as of the date of the acquisition (in thousands): Amount Estimated Useful Life Goodwill $ 321,152 Identified intangible assets: Developed technology 21,273 5 years Customer relationships 6,459 7 years Trade name 3,623 3 years Cash 4,407 Net liabilities assumed (4,063) Total $ 352,851 Goodwill generated from this acquisition was primarily attributable to the assembled workforce and expected post-acquisition synergies from combining Portworx container data services with our data services platform to expand our capabilities to support Kubernetes and containers. Goodwill was not deductible for tax purposes. The fair values of developed technology, customer relationships and trade name were derived by applying the excess earnings method, with-and-without method, and the relief-from-royalty method, respectively, all of which are under the income approach whose underlying inputs are considered Level 3. The fair values assigned to assets acquired and liabilities assumed were based on management's estimates and assumptions. In connection with the Portworx acquisition, we recorded a net deferred tax asset of $14.7 million. However, this amount was offset by a valuation allowance, thus, resulting in a net zero deferred tax asset during fiscal 2021. We continue to maintain a valuation allowance for our U.S. federal and state deferred tax assets. In addition, cash payments to certain former shareholders of Portworx totaling $32.2 million are being made over three years subject to continuous employment and are recognized as an operating expense. The remaining unpaid amount was $4.9 million at the end of fiscal 2023. The results of Portworx have been included in our consolidated statements of operations since the acquisition date and are not material. Pro forma results of operations have not been presented because the acquisition was not material to our results of operations. |
Balance Sheet Components
Balance Sheet Components | 12 Months Ended |
Feb. 05, 2023 | |
Balance Sheet Components Disclosure [Abstract] | |
Balance Sheet Components | Balance Sheet Components Inventory Inventory consists of the following (in thousands): At the End of Fiscal 2022 2023 Raw materials $ 15,734 $ 24,896 Finished goods 23,208 25,256 Inventory $ 38,942 $ 50,152 Property and Equipment, Net Property and equipment, net consists of the following (in thousands): At the End of Fiscal 2022 2023 Test equipment $ 266,672 $ 315,290 Computer equipment and software 206,053 262,574 Furniture and fixtures 8,652 9,693 Leasehold improvements 47,443 71,235 Capitalized software development costs 8,528 15,806 Total property and equipment 537,348 674,598 Less: accumulated depreciation and amortization (342,066) (402,153) Property and equipment, net $ 195,282 $ 272,445 Depreciation and amortization expense related to property and equipment was $57.1 million, $65.9 million and $87.0 million for fiscal 2021, 2022 and 2023, respectively. Intangible Assets, Net Intangible assets, net consist of the following (in thousands): At the End of Fiscal 2022 2023 Gross Carrying Value Accumulated Amortization Net Carrying Amount Gross Carrying Value Accumulated Amortization Net Carrying Amount Technology patents $ 19,125 $ (13,544) $ 5,581 $ 19,125 $ (14,826) $ 4,299 Developed technology 80,166 (30,304) 49,862 83,211 (43,366) 39,845 Customer relationships 6,459 (1,246) 5,213 6,459 (2,166) 4,293 Trade name 3,623 (1,633) 1,990 3,623 (2,838) 785 Intangible assets, net $ 109,373 $ (46,727) $ 62,646 $ 112,418 $ (63,196) $ 49,222 Intangible assets amortization expense was $13.0 million, $16.8 million and $16.5 million for fiscal 2021, 2022 and 2023, respectively. At the end of fiscal 2023, the weighted-average remaining amortization period was 1.6 years for technology patents, 3.0 years for developed technology, 4.7 years for customer relationships, and 0.6 years for trade name. We recorded amortization of technology patents in general and administrative expenses due to their defensive nature, developed technology in cost of product revenue, and customer relationships and trade name in sales and marketing expenses in the consolidated statements of operations. At the end of fiscal 2023, future expected amortization expense for intangible assets is as follows (in thousands): Fiscal Years Ending Future Expected 2024 $ 16,210 2025 15,425 2026 12,830 2027 3,107 2028 1,054 Thereafter 596 Total $ 49,222 Goodwill The change in the carrying amount of goodwill is as follows (in thousands): Amount Balance as of the end of fiscal 2022 $ 358,736 Goodwill acquired 2,691 Balance as of the end of fiscal 2023 $ 361,427 There were no impairments to goodwill during fiscal 2022 and 2023. Accrued Expenses and Other Liabilities Accrued expenses and other liabilities consist of the following (in thousands): At the End of Fiscal 2022 2023 Taxes payable $ 6,312 $ 16,615 Accrued marketing 13,257 14,228 Accrued cloud and outside services 6,135 7,644 Supply chain-related accruals (1) 6,991 23,545 Accrued service logistics and professional services 6,244 7,927 Acquisition earn-out and deferred consideration 5,211 3,556 Finance lease liabilities, current 1,035 5,432 Customer deposits from contracts with customers 10,409 17,824 Other accrued liabilities 22,917 26,978 Total accrued expenses and other liabilities $ 78,511 $ 123,749 _________________________________ (1) Primarily consist of warranty reserves and accruals related to our inventory and inventory purchase commitments with our contract manufacturers. |
Deferred Revenue and Commission
Deferred Revenue and Commissions | 12 Months Ended |
Feb. 05, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Deferred Revenue and Commissions | Deferred Revenue and Commissions Deferred Commissions Changes in total deferred commissions during the periods presented are as follows (in thousands): Fiscal Year Ended 2022 2023 Beginning balance $ 187,924 $ 246,307 Additions 217,595 155,414 Recognition of deferred commissions (159,212) (155,865) Ending balance $ 246,307 $ 245,856 During fiscal 2021, 2022 and 2023, we recognized sales commission expenses of $150.2 million, $175.9 million, and $170.0 million, respectively. Of the $245.9 million total deferred commissions balance at the end of fiscal 2023, we expect to recognize approximately 28% as sales commission expense over the next 12 months and the remainder thereafter. There was no impairment related to capitalized commissions for fiscal 2021, 2022 or 2023. Deferred Revenue Changes in total deferred revenue during the periods presented are as follows (in thousands): Fiscal Year Ended 2022 2023 Beginning balance $ 843,697 $ 1,079,872 Additions 937,510 1,248,417 Recognition of deferred revenue (701,335) (942,639) Ending balance $ 1,079,872 $ 1,385,650 During fiscal 2022 and 2023, we recognized approximately $442.7 million and $567.8 million, respectively, in revenue pertaining to deferred revenue as of the beginning of each period. Remaining Performance Obligations Total remaining performance obligations (RPO) which is contracted but not recognized revenue was $1.8 billion at the end of fiscal 2023. RPO consists of both deferred revenue and non-cancelable amounts that are expected to be invoiced and recognized as revenue in future periods. Product orders are generally cancelable until delivery has occurred, and as such unfulfilled product orders are excluded from RPO. Of the $1.8 billion RPO at the end of fiscal 2023, we expect to recognize approximately 47% over the next 12 months, and the remainder thereafter. |
Debt
Debt | 12 Months Ended |
Feb. 05, 2023 | |
Debt Disclosure [Abstract] | |
Debt | Debt Convertible Senior Notes In April 2018, we issued $575.0 million in principal amount of 0.125% convertible senior notes due 2023, in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act and received proceeds of $562.1 million, after deducting the underwriters’ discounts and commissions. The Notes are governed by an indenture (the Indenture) between us, as the issuer, and U.S. Bank National Association, as trustee. The Notes are our senior unsecured obligations. The Indenture does not contain any financial covenants or restrictions on the payments of dividends, the incurrence of indebtedness, or the issuance or repurchase of securities by us or any of our subsidiaries. The Notes will mature on April 15, 2023. Interest is payable semi-annually in arrears on April 15 and October 15 of each year. The Notes are convertible for up to 21,884,155 shares of our common stock at an initial conversion rate of approximately 38.0594 shares of common stock per $1,000 principal amount, which is equal to an initial conversion price of approximately $26.27 per share of common stock, subject to adjustment. On October 14, 2022, we provided notice to the holders electing to settle all conversions on or after October 15, 2022 with cash up to the principal amount of the Notes and shares for any excess conversion value. The conversion price will be subject to adjustment in some events. Following certain corporate events that occur prior to the maturity date or following our issuance of a notice of redemption, we will increase the conversion rate for a holder who elects to convert its Notes in connection with such corporate event or during the related redemption period in certain circumstances. Additionally, upon the occurrence of a corporate event that constitutes a “fundamental change” per the Indenture, holders of the Notes may require us to repurchase for cash all or a portion of the Notes at a purchase price equal to 100% of the principal amount of the Notes plus accrued and unpaid contingent interest. The Notes consisted of the following (in thousands): At the End of Fiscal 2022 2023 Liability: Principal $ 575,000 $ 575,000 Less: debt discount, net of amortization (1) (35,641) — Less: debt issuance costs, net of amortization (1) (2,580) (494) Net carrying amount of the Notes $ 536,779 $ 574,506 Stockholders' equity recorded at issuance: Allocated value of the conversion feature (1) $ 136,333 $ — Less: debt issuance costs (1) (3,068) — Additional paid-in capital $ 133,265 $ — _________________________________ (1) Fiscal 2023 reflects the adoption of ASU 2020-06 on February 7, 2022 using the modified retrospective method as described in Note 2. The total estimated fair values of the Notes at the end of fiscal 2022 and 2023 were $681.8 million and $660.0 million. The fair values were determined based on the closing trading price per $100 of the Notes as of the last day of trading of fiscal 2022 and 2023. The fair value of the Notes is primarily affected by the trading price of our common stock and market interest rates. Based on the closing price of our common stock of $29.91 on the last day of fiscal 2023, the if-converted value of the Notes of $654.6 million was greater than its principal amount. At the end of fiscal 2023, the remaining term of the Notes is approximately two months. The following table sets forth total interest expense recognized related to the Notes (in thousands): Fiscal Year Ended 2022 2023 Amortization of debt discount (1) $ 28,874 $ — Amortization of debt issuance costs (1) 2,091 2,598 Total amortization of debt discount and debt issuance costs 30,965 2,598 Contractual interest expense 732 716 Total interest expense related to the Notes $ 31,697 $ 3,314 Effective interest rate of the liability component 5.6 % 0.6 % _________________________________ (1) Fiscal 2023 reflects the adoption of ASU 2020-06 on February 7, 2022 using the modified retrospective method as described in Note 2. In connection with the offering of the Notes, we paid $64.6 million to enter into capped call transactions with certain of the underwriters and their affiliates (the Capped Calls), whereby we have the option to purchase up to a total of 21,884,155 shares of our common stock to offset the dilution and/or any cash payments we are required to make in excess of the principal amount upon conversion of the Notes at maturity, with such offset subject to a cap of $39.66 per share (which represents a premium of 100% over the last reported sales price of our common stock on April 4, 2018), subject to certain adjustments (the Cap Price). However, for conversions prior to maturity, the Capped Calls would be settled at their fair value, which may not completely offset, and may be substantially less than, the value of the consideration in excess of the principal amount of the Notes delivered upon such conversion. The cost of the Capped Calls was accounted for as a reduction to additional paid-in capital on the consolidated balance sheets. Impact on Earnings Per Share Subsequent to the adoption of ASU 2020-06, we compute the potentially dilutive shares of common stock related to the Notes for periods we report net income using the if-converted method. Upon conversion at maturity, there will be no economic dilution from the Notes until the average market price of our common stock exceeds the Cap Price of $39.66 per share as the exercise of the Capped Calls would offset any dilution from the Notes from the conversion price up to the Cap Price. Capped Calls are excluded from the calculation of diluted earnings per share, as they would be anti-dilutive. Revolving Credit Facility In August 2020, we entered into a Credit Agreement with a consortium of financial institutions and lenders that provides for a five-year, senior secured revolving credit facility of $300.0 million (Credit Facility). Proceeds from the Credit Facility may be used for general corporate purposes and working capital. The Credit Facility expires, absent default or early termination by us, on the earlier of (i) August 24, 2025 or (ii) 91 days prior to the stated maturity of the Notes unless, on such date and each subsequent day until the Notes are paid in full, the sum of our cash, cash equivalents and marketable securities and the aggregate unused commitments then available to us exceed $625.0 million. The annual interest rates applicable to loans under the Credit Facility are, at our option, equal to either a base rate plus a margin ranging from 0.50% to 1.25% or LIBOR (based on one, three or six-month interest periods), subject to a floor of 0%, plus a margin ranging from 1.50% to 2.25%. Interest on revolving loans is payable quarterly in arrears with respect to loans based on the base rate and at the end of an interest period in the case of loans based on LIBOR (or at each three-month interval if the interest period is longer than three months). We are also required to pay a commitment fee on the unused portion of the commitments ranging from 0.25% to 0.40% per annum, payable quarterly in arrears. In March 2021, the ICE Benchmark Administration, the administrator of LIBOR, announced that it will cease publication of LIBOR by June 2023. In March 2023, we amended the Credit Facility to transition LIBOR to the Secured Overnight Financing Rate (SOFR) effective April 1, 2023. The annual interest rate for SOFR borrowings will be equal to term SOFR (based on one, three or six-month interest periods), subject to a floor of 0%, plus a margin ranging from 1.50% to 2.25%. In February 2022, we repaid, in full, the $250.0 million outstanding under the Credit Facility. Prior to repayment, the outstanding loan bore weighted-average interest at the one-month LIBOR of approximately 1.65% and 1.60% resulting in interest expense of $1.4 million and $4.1 million during fiscal 2021 and 2022 and 1.61% resulting in interest expense of $0.3 million during the first quarter of fiscal 2023. Loans under the Credit Facility are collateralized by substantially all of our assets and subject to certain restrictions and two financial ratios measured as of the last day of each fiscal quarter: a Consolidated Leverage Ratio not to exceed 4.5:1 and an Interest Coverage Ratio not to be less than 3:1. We were in compliance with all covenants under the Credit Facility at the end of fiscal 2023. |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Feb. 05, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Leases At the end of fiscal 2023, we had various non-cancelable operating and finance lease commitments for office facilities. Refer to Note 9—Leases for additional information regarding lease commitments. Contractual Purchase Obligations At the end of fiscal 2023, we had $445.0 million of non-cancelable contractual purchase obligations primarily related to inventory purchase commitments, software service contracts, and hosting arrangements. In order to manage future demand for our products, we enter into agreements with manufacturers and suppliers to procure inventory based upon our demand forecasts. Letters of Credit At the end of fiscal 2022 and 2023, we had outstanding letters of credit in the aggregate amount of $6.7 million and $8.0 million in connection with our facility leases. The letters of credit are collateralized by either restricted cash or the Credit Facility and mature on various dates through September 2030. Legal Matters From time to time, we have become involved in claims and other legal matters arising in the normal course of business. We investigate these claims as they arise. Although claims are inherently unpredictable, we currently are not aware of any matters that we expect to have a material adverse effect on our business, financial position, results of operations or cash flows. Accordingly, no material loss contingency has been recorded on our consolidated balance sheet as of the end of fiscal 2023. Indemnification Our arrangements generally include certain provisions for indemnifying customers against liabilities if our products or services infringe a third party’s intellectual property rights. Other guarantees or indemnification arrangements include guarantees of product and service performance and standby letters of credit for lease facilities. It is not possible to determine the maximum potential amount under these indemnification obligations due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each particular agreement. To date, we have not incurred any material costs as a result of such obligations and have not accrued any liabilities related to such obligations in the consolidated financial statements. In addition, we indemnify our officers, directors and certain key employees while they are serving in good faith in their respective capacities. To date, there have been no claims under any indemnification provisions. |
Leases
Leases | 12 Months Ended |
Feb. 05, 2023 | |
Leases [Abstract] | |
Leases | LeasesWe lease office facilities under non-cancelable operating lease agreements expiring through July 2032. Our lease agreements do not contain any material residual value guarantees or restrictive covenants. In June 2022, we entered into an eight-year sublease through July 2030 for a new headquarters facility in Santa Clara, California with total lease payments of $100.2 million that include rent escalation and abatement clauses. The sublease of space with total lease payments of $89.4 million commenced in August 2022. Additional space with lease payments of $10.8 million will commence in May 2024 and end in July 2030 and therefore are excluded from our future lease payments disclosure below. During fiscal 2021, we ceased use of certain leased facilities that resulted in the recognition of certain exit costs - see Note 10 for further information. We also lease certain engineering test equipment under financing agreements. These finance leases are three years and contain a bargain purchase option at the end of the respective lease term. It is reasonably certain that the bargain purchase option will be exercised. The components of lease costs were as follows (in thousands): Fiscal Year Ended 2021 2022 2023 Fixed operating lease cost $ 37,411 $ 37,598 $ 47,533 Variable lease cost (1) 9,168 10,228 8,521 Short-term lease cost (12 months or less) 5,734 4,178 3,787 Finance lease cost: Amortization of finance lease right-of-use assets — 384 3,028 Interest on finance lease liabilities — 42 330 Total finance lease cost $ — $ 426 $ 3,358 Total lease cost $ 52,313 $ 52,430 $ 63,199 _________________________________ (1) Variable lease cost predominantly included common area maintenance charges. Supplemental information related to leases is as follows (in thousands): Fiscal Year Ended 2022 2023 Operating leases: Weighted-average remaining lease term (in years) 4.5 5.2 Weighted-average discount rate 5.7 % 6.1 % Finance leases: Finance lease right-of-use assets, gross (1) $ 3,577 $ 17,596 Accumulated amortization (1) (384) (3,412) Finance lease right-of-use assets, net (1) $ 3,193 $ 14,184 Finance lease liabilities, current (2) 1,035 5,432 Finance lease liabilities, non-current (3) 1,487 4,765 Total finance lease liabilities $ 2,522 $ 10,197 Weighted-average remaining lease term (in years) 3.6 3.3 Weighted-average discount rate 2.7 % 5.1 % ____________________________________ (1) Included in the consolidated balance sheets within property and equipment, net. (2) Included in the consolidated balance sheets within accrued expenses and other liabilities (3) Included in the consolidated balance sheets within other liabilities, non-current Supplemental cash flow information related to leases is as follows (in thousands): Fiscal Year Ended 2022 2023 Cash paid for amounts included in the measurement of lease liabilities: Operating cash outflows for operating leases $ 36,648 $ 49,955 Financing cash outflows for finance leases $ 1,000 $ 6,138 Right-of-use assets obtained in exchange for lease liabilities: Operating leases $ 7,517 $ 80,962 Finance leases $ 3,577 $ 14,019 Future lease payments under our non-cancelable leases at the end of fiscal 2023 are as follows (in thousands): Fiscal Years Ending Operating Leases Finance Leases 2024 $ 45,153 $ 5,839 2025 48,315 4,728 2026 36,366 183 2027 19,384 — 2028 21,062 — Thereafter 44,274 — Total future lease payments $ 214,554 $ 10,750 Less: imputed interest (38,374) (553) Present value of total lease liabilities $ 176,180 $ 10,197 |
Restructuring and Other
Restructuring and Other | 12 Months Ended |
Feb. 05, 2023 | |
Restructuring and Related Activities [Abstract] | |
Restructuring and Other | Restructuring and Other During fiscal 2021, we carried out the following restructuring and other activities: • We ceased use of certain leased facilities and recorded an impairment charge of $7.5 million for operating lease right-of-use assets and leasehold improvements for these leases. In addition, we recognized a liability of $2.4 million for the remaining lease costs that will continue to be incurred without benefit to us. • We effected workforce realignment plans to streamline our operations and recognized $12.2 million of restructuring costs related to one-time involuntary termination benefit costs. The restructuring charges are included in restructuring and other expenses in our consolidated statement of operations. All amounts were paid prior to the end of fiscal 2022. • We incurred incremental costs of $9.8 million directly related to the COVID-19 pandemic. These costs primarily included the write-off of marketing commitments no longer deemed to have value for the remainder of fiscal 2021, estimated non-recoverable costs for internal events that could not be held, and hazard related premiums to support manufacturing operations. Of these costs, $8.9 million is included in restructuring and other expenses and $0.9 million is included in cost of revenue in our consolidated statements of operations for fiscal 2021. |
Stockholders' Equity
Stockholders' Equity | 12 Months Ended |
Feb. 05, 2023 | |
Equity [Abstract] | |
Stockholders’ Equity | Stockholders’ Equity Preferred Stock We have 20,000,000 authorized shares of undesignated preferred stock, the rights, preferences and privileges of which may be designated from time to time by our Board of Directors. At the end of fiscal 2023, there were no shares of preferred stock issued or outstanding. Class A and Class B Common Stock We have two classes of authorized common stock, Class A common stock, which we refer to as our "common stock", and Class B common stock. We have 2,000,000,000 authorized shares of Class A common stock and 250,000,000 authorized shares of Class B common stock, with each class having a par value of $0.0001 per share. At the end of fiscal 2023, 304,076,234 shares of Class A common stock were issued and outstanding. Common Stock Reserved for Issuance At the end of fiscal 2023, we had reserved shares of common stock for future issuance as follows: Shares underlying outstanding stock options 9,268,498 Shares underlying outstanding restricted stock units 26,760,520 Shares reserved for future equity awards 20,661,582 Shares reserved for future employee stock purchase plan awards 5,309,812 Total 62,000,412 Share Repurchase Program In August 2019, our Board of Directors approved a stock repurchase program to repurchase up to $150.0 million of our common stock, which was completed in the fourth quarter of fiscal 2021. In February 2021, our Board of Directors authorized the repurchase of up to an additional $200.0 million of our common stock, which was completed in the fourth quarter of fiscal 2022. In March 2022, our Board of Directors authorized the repurchase of up to an additional $250.0 million of our common stock, of which $31.1 million remained available at the end of fiscal 2023. In March 2023, our Board of Directors authorized the repurchase of up to an additional $250.0 million of our common stock. The authorization allows us to repurchase shares of our common stock opportunistically and will be funded from available working capital. Repurchases may be made at management’s discretion from time to time on the open market through privately negotiated transactions, transactions structured through investment banking institutions, block purchase techniques, 10b5-1 trading plans, or a combination of the foregoing. The share repurchase program does not obligate us to acquire any of our common stock, has no end date, and may be suspended or discontinued by us at any time without prior notice. |
Equity Incentive Plans
Equity Incentive Plans | 12 Months Ended |
Feb. 05, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Equity Incentive Plans | Equity Incentive Plans Equity Incentive Plans We maintain two equity incentive plans: the 2009 Equity Incentive Plan (the 2009 Plan) and the 2015 Equity Incentive Plan (the 2015 Plan). The 2015 Plan serves as the successor to our 2009 Plan and provides for grants of incentive stock options to our employees and non-statutory stock options, stock appreciation rights, restricted stock, RSUs, performance stock awards, performance cash awards, and other forms of stock awards to our employees, directors and consultants. Our equity awards generally vest over a two We initially reserved 27,000,000 shares of our common stock for issuance under our 2015 Plan. The number of shares reserved for issuance under our 2015 Plan increases automatically on the first day of each fiscal year, for a period of not more than ten years, commencing on February 1, 2016, in an amount equal to 5% of the total number of shares of our capital stock outstanding as of the immediately preceding January 31 (the Evergreen Increase). In March 2022, our Board of Directors approved an amendment and restatement of the 2015 Plan to clarify the effect of our change to a 52/53 week fiscal year in September 2019 on the Evergreen Increase. We net-share settle equity awards held by certain employees by withholding shares upon vesting to satisfy tax withholding obligations. The shares withheld to satisfy employee tax withholding obligations are returned to our 2015 Plan and will be available for future issuance. Payments for employees’ tax obligations to the tax authorities are recognized as a reduction to additional paid-in capital and reflected as a financing activity in our consolidated statements of cash flows. 2015 Amended and Restated Employee Stock Purchase Plan Our 2015 Employee Stock Purchase Plan was amended and restated in fiscal 2020 (2015 ESPP). A total of 3,500,000 shares of common stock was initially reserved for issuance under the 2015 ESPP and an additional 5,000,000 shares of common stock were added in connection with the amendment and restatement. The number of shares reserved for issuance under our 2015 ESPP increases automatically on the first day of February of each of 2016 through 2025, in an amount equal to the lesser of (i) 1% of the total number of shares of our capital stock outstanding as of the immediately preceding January 31, and (ii) 3,500,000 shares of common stock. Our Board of Directors (or a committee thereof) has the authority to establish the length and terms of the offering periods and purchase periods and the purchase price of the shares of common stock which may be purchased under the plan. The current offering terms allow eligible employees to purchase shares of our common stock at a discount through payroll deductions of up to 30% of their eligible compensation, subject to a cap of 3,000 shares on any purchase date, a dollar cap of $7,500 per purchase period, or $25,000 in any calendar year (as determined under applicable tax rules). The current terms also allow for a 24-month offering period beginning March 16th and September 16th of each year, with each offering period consisting of four 6 month purchase periods, subject to a reset provision. Further, currently, on each purchase date, eligible employees may purchase our common stock at a price per share equal to 85% of the lesser of the fair market value of our common stock (1) on the first trading day of the applicable offering period or (2) the purchase date. Under the reset provision currently authorized, if the closing stock price on the offering date of a new offering falls below the closing stock price on the offering date of an ongoing offering, the ongoing offering would terminate immediately following the purchase of ESPP shares on the purchase date immediately preceding the new offering and participants in the terminated ongoing offering would automatically be enrolled in the new offering (ESPP reset), resulting in a modification charge to be recognized over the new offering period. During fiscal 2021 and 2023, ESPP resets resulted in total modification charges of $23.8 million and $10.4 million, respectively, to be recognized over their new offering periods. There was no ESPP reset during fiscal 2022. During fiscal 2021, 2022 and 2023, we recognized $25.8 million, $35.4 million and $22.9 million, of stock-based compensation expense related to our 2015 ESPP. At the end of fiscal 2023, total unrecognized stock-based compensation cost related to our 2015 ESPP was $31.5 million, which is expected to be recognized over a weighted-average period of approximately 1.6 years. Stock Options A summary of the stock option activity under our equity incentive plans and related information is as follows: Options Outstanding Number of Weighted- Weighted- Aggregate Balance at the end of fiscal 2022 12,268,938 $ 10.25 3.5 $ 198,266 Options exercised (2,988,068) 8.29 Options forfeited (12,372) 1.83 Balance at the end of fiscal 2023 9,268,498 $ 10.90 2.7 $ 176,674 Vested and exercisable at the end of fiscal 2023 9,077,014 $ 11.04 2.6 $ 171,315 The aggregate intrinsic value of options vested and exercisable at the end of fiscal 2023 is calculated based on the difference between the exercise price and the closing price of $29.91 of our common stock on the last day of fiscal 2023. The aggregate intrinsic value of options exercised during fiscal 2021, 2022 and 2023 was $118.8 million, $105.1 million and $63.5 million. The total grant date fair value of options vested during fiscal 2021, 2022 and 2023 was $20.1 million, $16.5 million and $7.0 million. During fiscal 2021, 2022 and 2023, we recognized $8.6 million, $7.7 million and $4.9 million, of stock-based compensation expense related to stock options. At the end of fiscal 2023, total unrecognized employee stock-based compensation cost related to outstanding options was $2.4 million, which is expected to be recognized over a weighted-average period of 1.1 years. Determination of Fair Value The fair value of stock options granted to employees and to be purchased under ESPP is estimated on the grant date using the Black-Scholes option pricing model. This valuation model for stock-based compensation expense requires us to make assumptions and judgments about the variables used in the calculation including the fair value of the underlying common stock, expected term, the expected volatility of the common stock, a risk-free interest rate and expected dividend yield. The assumptions used for the periods presented are as follows: Fiscal Year Ended 2021 2022 2023 Employee Stock Options Expected term (in years) 5.65 n/a n/a Expected volatility 52.07% n/a n/a Risk-free interest rate 0.3% n/a n/a Dividend rate — n/a n/a Fair value of common stock $15.79 n/a n/a Employee Stock Purchase Plan Expected term (in years) 0.5 - 2.0 0.5 - 2.0 0.5 - 2.0 Expected volatility 52% - 113% 44% - 61% 45% - 54% Risk-free interest rate 0.1% - 0.4% 0.1% - 0.2% 0.9% - 4.0% Dividend rate — — — Fair value of common stock $9.07 - $15.26 $23.63 - $26.69 $28.73 - $31.68 The assumptions used in the Black-Scholes option pricing model were determined as follows. Fair Value of Common Stock —We use the market closing price of our common stock as reported on the New York Stock Exchange to determine the fair value of our common stock at each grant date. Expected Term —The expected term represents the period that our stock-based awards are expected to be outstanding. The expected term assumptions were determined based on the vesting terms, exercise terms and contractual lives of the stock options and ESPP purchase rights. Expected Volatility —The expected volatility for stock options and ESPP purchase rights is based on the historical volatility of our common stock for a period equivalent to the expected term of the stock option grants and ESPP purchase rights. Risk-Free Interest Rate —The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for zero-coupon U.S. Treasury notes with maturities approximately equal to the expected term of the stock option grants and ESPP purchase rights. Dividend Rate —We have never declared or paid any cash dividends and do not plan to pay cash dividends in the foreseeable future, and, therefore, use an expected dividend yield of zero. RSUs and PRSUs A summary of the RSU and PRSU activity under our equity incentive plans and related information is as follows: Number of RSUs and PRSUs Outstanding Weighted-Average Grant Date Fair Value Aggregate Intrinsic Value Unvested balance at the end of fiscal 2022 28,712,878 $ 19.53 $ 757,446 Granted 15,319,768 29.67 Vested (13,915,802) 20.05 Forfeited (3,356,324) 21.75 Unvested balance at the end of fiscal 2023 26,760,520 $ 24.78 $ 800,407 During fiscal 2023, we granted 1,147,187 shares of PRSUs, at a target percentage of 100%, with both performance and service vesting conditions payable in common stock, from 0% to 150% of the target number granted, contingent upon the degree to which the fiscal 2023 performance condition is met. A total of 1,770,282 shares of PRSUs were earned at the end of fiscal 2023 based on the fiscal 2023 performance conditions achieved and a portion of these shares are subject to service conditions through the remaining vesting periods. The incremental shares of PRSUs earned will be granted in the first quarter of fiscal 2024. The aggregate fair value, as of the respective vesting dates, of RSUs and PRSUs that vested during fiscal 2021, 2022 and 2023 was $183.4 million, $322.2 million and $402.7 million. During fiscal 2021, 2022 and 2023, we recognized $199.1 million, $242.1 million and $299.7 million in stock-based compensation expense related to RSUs and PRSUs. At the end of fiscal 2023, total unrecognized employee compensation cost related to unvested RSUs and PRSUs was $588.4 million, which is expected to be recognized over a weighted-average period of 2.7 years. Restricted Stock A summary of the restricted stock activity under our 2015 Plan and related information is as follows: Number of Restricted Stock Outstanding Weighted- Aggregate Unvested balance at the end of fiscal 2022 54,977 $ 20.02 $ 1,450 Vested (54,977) 20.02 Forfeited — — Unvested balance at the end of fiscal 2023 — $ — $ — The aggregate fair value of restricted stock that vested during fiscal 2021, 2022 and 2023 was $18.3 million, $10.4 million and $1.9 million. During fiscal 2021 and 2022, we recognized $9.3 million and $1.8 million in stock-based compensation expense related to restricted stock. The remaining stock-based compensation expense recognized related to restricted stock was not material during fiscal 2023. Stock-Based Compensation Expense The following table summarizes the components of stock-based compensation expense recognized in the consolidated statements of operations (in thousands): Fiscal Year Ended 2021 2022 2023 Cost of revenue—product $ 4,001 $ 6,334 $ 10,245 Cost of revenue—subscription services 14,979 21,240 22,630 Research and development 117,220 142,264 161,694 Sales and marketing 65,248 71,439 72,507 General and administrative 40,896 45,686 60,541 Total stock-based compensation expense $ 242,344 $ 286,963 $ 327,617 The tax benefit related to stock-based compensation expense for all periods presented was not material. |
Net Income (Loss) per Share Att
Net Income (Loss) per Share Attributable to Common Stockholders | 12 Months Ended |
Feb. 05, 2023 | |
Earnings Per Share [Abstract] | |
Net Income (Loss) per Share Attributable to Common Stockholders | Net Income (Loss) per Share Attributable to Common StockholdersBasic and diluted net income (loss) per share attributable to common stockholders is presented in conformity with the two-class method required for participating securities. Basic net income (loss) per share attributable to common stockholders is computed by dividing the net income (loss) attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period, less shares subject to repurchase. Diluted net income (loss) per share attributable to common stockholders is computed by giving effect to all potentially dilutive common stock equivalents, including our outstanding stock options, common stock related to unvested RSUs and PRSUs, unvested restricted stock, the shares underlying the conversion option in our Notes to the extent dilutive, and common stock issuable pursuant to the ESPP. The adoption of ASU 2020-06 at the beginning of fiscal 2023 eliminates the treasury stock method and instead requires the application of the if-converted method to calculate the impact of our Notes on diluted EPS. Using this method, the numerator is affected by adding back interest expense related to the Notes and the denominator is affected by including the effect of potential share settlement, if the effect is dilutive. All potentially dilutive common stock equivalents, including from our Notes, have been excluded from the calculation of diluted net loss per share attributable to common stockholders in periods of net loss as their effect is anti-dilutive. The following table sets forth the computation of basic and diluted net income (loss) per share attributable to common stockholders (in thousands, except per share data): Fiscal Year Ended 2021 2022 2023 Numerator: Net income (loss) attributable to common stockholders, basic $ (282,076) $ (143,259) $ 73,071 Add: Interest charges related to our Notes — — 3,314 Net income (loss) attributable to common stockholders, diluted $ (282,076) $ (143,259) $ 76,385 Denominator: Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, basic 267,824 285,882 299,478 Add: Dilutive effect of common stock equivalents — — 39,706 Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, diluted 267,824 285,882 339,184 Net income (loss) per share attributable to common stockholders, basic $ (1.05) $ (0.50) $ 0.24 Net income (loss) per share attributable to common stockholders, diluted $ (1.05) $ (0.50) $ 0.23 The following weighted-average outstanding shares of common stock equivalents were excluded from the computation of diluted net income (loss) per share attributable to common stockholders for the periods presented because including them would have been anti-dilutive (in thousands): Fiscal Year Ended 2021 2022 2023 Stock options to purchase common stock 23,180 15,686 10,516 Unvested RSUs and PRSUs 31,980 32,491 29,780 Unvested restricted stock 1,145 257 6 Shares related to convertible senior notes 21,884 21,884 — Shares issuable pursuant to the ESPP 2,148 2,122 885 Total 80,337 72,440 41,187 |
Other Income (Expense), Net
Other Income (Expense), Net | 12 Months Ended |
Feb. 05, 2023 | |
Other Income and Expenses [Abstract] | |
Other Income (Expense), Net | Other Income (Expense), Net Other income (expense), net consists of the following (in thousands): Fiscal Year Ended 2021 2022 2023 Interest income (1) $ 17,442 $ 9,371 $ 17,320 Interest expense (2) (31,403) (36,677) (4,749) Foreign currency transactions gains (losses) 2,507 (5,235) (8,345) Other income 2,327 2,443 4,069 Total other income (expense), net $ (9,127) $ (30,098) $ 8,295 _________________________________ (1) Interest income includes interest income related to our cash, cash equivalents and marketable securities and non-cash interest income (expense) related to accretion (amortization) of the discount (premium) on marketable securities. (2) Interest expense includes non-cash interest expense related to amortization of debt discount and debt issuance costs, contractual interest expense related to our debt and accretion of our finance lease liabilities. |
Income Taxes
Income Taxes | 12 Months Ended |
Feb. 05, 2023 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The geographical breakdown of income (loss) before provision for income taxes is as follows (in thousands): Fiscal Year Ended 2021 2022 2023 Domestic $ (312,119) $ (192,058) $ 39,004 International 41,959 63,562 52,804 Total $ (270,160) $ (128,496) $ 91,808 The components of the provision for income taxes are as follows (in thousands): Fiscal Year Ended 2021 2022 2023 Current: State $ 442 $ 592 $ 5,999 Foreign 8,006 12,525 12,020 Total $ 8,448 $ 13,117 $ 18,019 Deferred: Federal $ (218) $ — $ (639) State — — (99) Foreign 3,686 1,646 1,456 Total $ 3,468 $ 1,646 $ 718 Provision for income taxes $ 11,916 $ 14,763 $ 18,737 The reconciliation of income taxes at the federal statutory income tax rate to the provision for income taxes is as follows (in thousands): Fiscal Year Ended 2021 2022 2023 Tax at federal statutory rate $ (56,734) $ (26,984) $ 19,280 State tax, net of federal benefit 349 468 4,625 Stock-based compensation expense (604) (19,658) (11,976) Research and development tax credits (14,138) (16,783) (26,634) U.S. taxes on foreign income 14,021 25,059 19,065 Foreign rate differential 2,282 (1,698) (425) Withholding tax 34 143 2,339 Change in valuation allowance 63,146 48,270 10,631 Non-deductible expenses — 4,381 2,091 Other 3,560 1,565 (259) Provision for income taxes $ 11,916 $ 14,763 $ 18,737 Deferred income taxes reflect the net effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The significant components of our deferred tax assets and liabilities were as follows (in thousands): At the End of Fiscal 2022 2023 Deferred tax assets: Net operating loss carryforwards $ 369,904 $ 198,495 Tax credit carryover 134,085 171,775 Accruals and reserves 22,625 34,506 Deferred revenue 66,242 87,026 Stock-based compensation expense 25,247 25,564 ASC 842 lease liabilities 28,577 40,772 Capitalized research and development — 154,027 Other 1,879 4,950 Total deferred tax assets $ 648,559 $ 717,115 Valuation allowance (554,553) (598,997) Total deferred tax assets, net of valuation allowance $ 94,006 $ 118,118 Deferred tax liabilities: Depreciation and amortization $ (12,992) $ (31,744) Deferred commissions (53,219) (53,421) Convertible debt (4,642) — ASC 842 right-of-use assets (24,608) (36,366) Acquired intangibles and goodwill (6,850) (4,702) Interest income (874) (2,521) Total deferred tax liabilities $ (103,185) $ (128,754) Net deferred tax liabilities $ (9,179) $ (10,636) At the end of fiscal 2023, the undistributed earnings of $176.2 million from non-U.S. operations held by our foreign subsidiaries are designated as permanently reinvested outside the U.S. Accordingly, no additional U.S. income taxes or additional foreign withholding taxes have been provided thereon. Determination of the amount of unrecognized deferred tax liability related to these earnings is not practicable. At the end of fiscal 2023, we had net operating loss carryforwards for federal income tax purposes of approximately $795.1 million and state income tax purposes of approximately $578.0 million. The federal net operating loss carryforwards have an indefinite life while the state net operating loss carryforwards begin to expire in 2025. We had federal and state research and development tax credit carryforwards of approximately $134.2 million and $116.0 million at the end of fiscal 2023. The federal research and development tax credit carryforwards will expire commencing in 2028, while the state research and development tax credit carryforwards have no expiration date. Starting in fiscal 2023, changes to Section 174 of the Internal Revenue Code made by the Tax Cuts and Jobs Act of 2017 no longer permit an immediate deduction for research and development expenditures in the tax year that such costs are incurred. These costs are capitalized resulting in an increase in deferred tax assets and state income taxes. Realization of deferred tax assets is dependent on future taxable income, the existence and timing of which is uncertain. Based on our history of losses, management has determined that it is more likely than not that the U.S. deferred tax assets will not be realized, and accordingly has placed a full valuation allowance on the net U.S. deferred tax assets. The valuation allowance increased by $70.1 million and $44.4 million, respectively, during fiscal 2022 and 2023. Utilization of the net operating loss carryforwards and credits may be subject to substantial annual limitation due to the ownership change limitations provided by Section 382 of the Internal Revenue Code of 1986, as amended, and similar state provisions. The annual limitation may result in the expiration of net operating losses and credits before utilization. Uncertain Tax Positions The activity related to the unrecognized tax benefits is as follows (in thousands): Fiscal Year Ended 2021 2022 2023 Gross unrecognized tax benefits—beginning balance $ 28,570 $ 39,571 $ 51,582 Decreases related to tax positions taken during prior years (345) (173) — Increases related to tax positions taken during prior years 1,881 1,201 2,172 Increases related to tax positions taken during current year 9,465 10,983 15,143 Gross unrecognized tax benefits—ending balance $ 39,571 $ 51,582 $ 68,897 At the end of fiscal 2023, our gross unrecognized tax benefit was approximately $68.9 million, $6.2 million of which if recognized, would have an impact on the effective tax rate. At the end of fiscal 2023, we had no current or cumulative interest and penalties related to uncertain tax positions. It is difficult to predict the final timing and resolution of any particular uncertain tax position. Based on our assessment, including experience and complex judgments about future events, we do not expect that changes in the liability for unrecognized tax benefits during the next twelve months will have a significant impact on our consolidated financial position or results of operations. We file income tax returns in the U.S. federal jurisdiction as well as many U.S. states and foreign jurisdictions. The tax returns for fiscal years 2009 and forward remain open to examination by the major jurisdictions in which we are subject to tax. The tax returns for fiscal years outside the normal statutes of limitation remain open to audit by tax authorities due to tax attributes generated in those early years, which have been carried forward and may be audited in subsequent years when utilized. |
Segment Information
Segment Information | 12 Months Ended |
Feb. 05, 2023 | |
Segment Reporting [Abstract] | |
Segment Information | Segment Information Our chief operating decision maker is our Chief Executive Officer. Our chief operating decision maker reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance. Accordingly, we have a single reportable segment. Disaggregation of Revenue The following table depicts the disaggregation of revenue by geographic area based on the billing address of our customers and is consistent with how we evaluate our financial performance (in thousands): Fiscal Year Ended 2021 2022 2023 United States $ 1,195,428 $ 1,580,022 $ 1,971,757 Rest of the world 488,751 600,826 781,677 Total revenue $ 1,684,179 $ 2,180,848 $ 2,753,434 Long-Lived Assets by Geographic Area Long-lived assets, which are comprised of property and equipment, net, by geographic area are summarized as follows (in thousands): At the End of Fiscal 2022 2023 United States $ 187,228 $ 259,131 Rest of the world 8,054 13,314 Total long-lived assets $ 195,282 $ 272,445 |
401(k) Plan
401(k) Plan | 12 Months Ended |
Feb. 05, 2023 | |
Compensation Related Costs [Abstract] | |
401(k) Plan | 401(k) PlanWe have a 401(k) savings plan (the 401(k) plan) which qualifies as a deferred salary arrangement under section 401(k) of the Internal Revenue Code. Under the 401(k) plan, participating employees may elect to contribute up to 85% of their eligible compensation, subject to certain limitations. We currently match 50% of employees' contributions up to a maximum of $4,000 annually. Matching contributions immediately vest. Our contributions to the plan were $10.2 million, $11.1 million and $12.2 million during fiscal 2021, 2022 and 2023. |
Basis of Presentation and Sum_2
Basis of Presentation and Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Feb. 05, 2023 | |
Accounting Policies [Abstract] | |
Basis of Presentation and Principles of Consolidation | Basis of Presentation and Principles of Consolidation We operate using a 52/53 week fiscal year ending on the first Sunday after January 30. Fiscal 2021 and 2023 were both 52-week years that ended on January 31, 2021 and February 5, 2023, respectively. Fiscal 2022 was a 53-week year that ended on February 6, 2022. Unless otherwise stated, all dates refer to our fiscal years. The consolidated financial statements include the accounts of the Company and our wholly owned subsidiaries and have been prepared in conformity with accounting principles generally accepted in the United States (U.S. GAAP). All intercompany balances and transactions have been eliminated in consolidation. |
Foreign Currency | Foreign Currency The functional currency of our foreign subsidiaries is the U.S. dollar. Transactions denominated in currencies other than the functional currency are remeasured to the functional currency at the average exchange rate in effect during the period. At the end of each reporting period, monetary assets and liabilities are remeasured using exchange rates in effect at the balance sheet date. Non-monetary assets and liabilities are remeasured at historical exchange rates. Foreign currency transaction gains and losses are recorded in other income (expense), net in the consolidated statements of operations. |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and accompanying notes. Actual results could differ from these estimates and assumptions due to risks and uncertainties. Such estimates include, but are not limited to, the determination of standalone selling price for revenue arrangements with multiple performance obligations when the price at which the performance obligation sold separately or observable past transactions are not available, useful lives of intangible assets and property and equipment, the period of benefit for deferred contract costs for commissions, stock-based compensation, provision for income taxes including related reserves, fair value of equity assumed, intangible and tangible assets acquired and liabilities assumed for business combinations. Management bases its estimates on historical experience and on various other assumptions which management believes to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. |
Concentration Risk | Concentration RiskFinancial instruments that are exposed to concentration of credit risk consist primarily of cash and cash equivalents, marketable securities, and accounts receivable. |
Cash and Cash Equivalents | Cash and Cash Equivalents Cash and cash equivalents consist of cash in banks and highly liquid investments, primarily money market accounts and U.S. government treasury notes, purchased with an original maturity of three months or less. |
Marketable Securities | Marketable Securities We classify our marketable securities as available-for-sale (AFS) at the time of purchase and reevaluate such classification at each balance sheet date. We may sell these securities at any time for use in current operations even if they have not yet reached maturity. As a result, we classify our securities, including those with maturities beyond twelve months, as current assets in the consolidated balance sheets. We carry these securities at estimated fair value and record unrealized gains and losses in accumulated other comprehensive income (loss), which is reflected as a component of stockholders' equity. We evaluate our AFS debt securities with an unamortized cost basis in excess of estimated fair value to determine what amount of that difference, if any, is caused by expected credit losses. Credit-related impairment losses, not to exceed the amount that fair value is less than the amortized cost basis, are recognized through an allowance for credit losses with changes in the allowance for credit losses recognized as a charge to other income (expense), net, in the consolidated statements of operations. Any remaining impairment is included in accumulated other comprehensive income (loss) as a component of stockholders' equity. Realized gains and losses from the sale of marketable securities are determined based on the specific identification method. Realized gains and losses are reported in other income (expense), net in the consolidated statements of operations. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The carrying value of our financial instruments, including cash equivalents, accounts receivable, accounts payable and accrued liabilities, approximates fair value. |
Accounts Receivable and Allowance | Accounts Receivable and Allowance Accounts receivable are recorded at the invoiced amount, and stated at realizable value, net of an allowance for doubtful accounts. Credit is extended to partners and customers based on an evaluation of their financial condition and other factors. We generally do not require collateral or other security to support accounts receivable. We perform ongoing credit evaluations and maintain an allowance for doubtful accounts. We assess the collectability of the accounts by taking into consideration the aging of our trade receivables, historical experience, and management judgment. We write off trade receivables against the allowance when management determines a balance is uncollectible and no longer actively pursues collection of the receivable. |
Restricted Cash | Restricted CashRestricted cash is comprised of cash collateral for letters of credit related to our leases and for a vendor credit card program. |
Inventory | Inventory Inventory consists of finished goods and component parts, which are purchased from contract manufacturers. Product demonstration units, which we regularly sell, are the primary component of our inventories. Inventories are stated at the lower of cost or net realizable value. Cost is determined using the specific identification method for finished goods and weighted-average method for component parts. We account for excess and obsolete inventory by reducing the carrying value to the estimated net realizable value of the inventory based upon management’s assumptions about future demand and market conditions. In addition, we record a liability for firm, non-cancelable and unconditional purchase commitments with contract manufacturers and suppliers for quantities in excess of future demand forecasts consistent with excess and obsolete inventory valuations. Inventory write-offs were insignificant for fiscal 2021, 2022 and 2023. |
Property and Equipment, Net | Property and Equipment, Net Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation and amortization is computed using the straight-line method over the estimated useful lives of the respective assets (test equipment—4 years, computer equipment and software—4 to 5 years, furniture and fixtures—7 years). Leasehold improvements are amortized over the shorter of their estimated useful lives or the remaining lease term. Depreciation commences once the asset is placed in service. In accordance with our accounting practices, we review the estimated useful lives of our property and equipment on an ongoing basis. In the first quarter of fiscal 2021, management determined that the estimated useful lives of its test equipment and certain computer equipment and software required revision. The estimated useful lives of test equipment and certain computer equipment and software were revised to 4 years. Previously, the estimated useful lives of these assets ranged from 2 to 3 years. The change in estimated useful lives was accounted for as a change in estimate and recognized on a prospective basis effective February 3, 2020. The effect of this change in estimate resulted in a reduction to depreciation expense of $23.6 million during fiscal 2021. |
Business Combinations | Business Combinations We allocate the purchase price to the assets acquired and liabilities assumed based on their estimated fair values. The excess of the purchase price over the fair values of the assets acquired and liabilities assumed is recorded as goodwill. During the measurement period, which may be up to one year from the acquisition date, we may record adjustments to the estimated fair value of the assets acquired and liabilities assumed, with the corresponding offset to goodwill. The results of operations of an acquired business is included in our consolidated financial statements from the date of acquisition. Acquisition-related expenses are expensed as incurred. |
Goodwill | Goodwill Goodwill represents the excess of the purchase price consideration over the estimated fair value of the tangible and intangible assets acquired and liabilities assumed in a business combination. Goodwill is evaluated for impairment annually in the fourth quarter of our fiscal year as a single reporting unit, and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. We may elect to qualitatively assess whether it is more likely than not that the fair value of our reporting unit is less than its carrying value. If we opt not to qualitatively assess, a quantitative goodwill impairment test is performed. The quantitative test compares our reporting unit's carrying amount, including goodwill, to its fair value calculated based on our enterprise value. If the carrying amount exceeds its fair value, an impairment loss is recognized for the excess. |
Purchased Intangible Assets | Purchased Intangible Assets Purchased intangible assets with finite lives are stated at cost, net of accumulated amortization. We amortize our intangible assets on a straight-line basis over an estimated useful life of three |
Impairment of Long-Lived Assets | Impairment of Long-Lived Assets We review our long-lived assets, including property and equipment and finite-lived intangible assets, for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. We measure the recoverability of these assets by comparing the carrying amounts to the future undiscounted cash flows the assets are expected to generate. If the total of the future undiscounted cash flows is less than the carrying amount of an asset, we record an impairment charge for the amount by which the carrying amount of the asset exceeds its fair value. |
Convertible Senior Notes | Convertible Senior Notes Prior to the adoption of Accounting Standards Update (ASU) 2020-06 on February 7, 2022, in accounting for the issuance of our convertible senior notes (the Notes), we separated the Notes into liability and equity components. The carrying amount of the liability component was determined by measuring the fair value of a similar debt instrument that does not have an associated convertible feature. The carrying amount of the equity component representing the conversion option was calculated by deducting the fair value of the liability component from the principal amount of the Notes as a whole. This difference represented a debt discount that was amortized to interest expense using the effective interest method over the term of the Notes. The equity component of the Notes was included in additional paid-in capital in the consolidated balance sheets and was not remeasured as it continued to meet the conditions for equity classification. Transaction costs related to the issuance of the Notes (debt issuance costs) were allocated to the liability and equity components using the same proportions as the initial carrying value of the Notes. The debt issuance costs attributable to the liability component were netted with the principal amount of the Notes and amortized to interest expense using the effective interest method over the term of the Notes. The debt issuance costs attributable to the equity component were netted with the equity component of the Notes in additional paid-in capital. Upon adoption of ASU 2020-06, we combined the liability and equity components assuming that the instrument was accounted for as a single liability from inception to the date of adoption, resulting in the elimination of the debt discount. Similarly, the liability and equity components of the debt issuance costs were combined as a reduction to the Notes and is being amortized to interest expense using the effective interest method over the remaining term of the Notes. |
Deferred Commissions | Deferred Commissions Deferred commissions consist of incremental costs paid to our sales force to obtain customer contracts. Deferred commissions related to product revenue are recognized upon transfer of control to customers and deferred commissions related to subscription services revenue are amortized over an expected useful life of six years. We determine the expected useful life based on an estimated benefit period by evaluating our technology development life cycle, expected customer relationship period and other factors. We classify deferred commissions as current and non-current on our consolidated balance sheets based on the timing of when we expect to recognize the expense. Amortization of deferred commissions is included in sales and marketing expense in the consolidated statements of operations. |
Leases | Leases We determine if an arrangement contains a lease at inception and classify leases as an operating or finance lease at commencement date. Lease liabilities are recognized at the present value of the future lease payments at commencement date. The interest rate implicit in our operating and finance leases is not readily determinable, and therefore an incremental borrowing rate is estimated to determine the present value of future payments. The estimated incremental borrowing rate factors in a hypothetical interest rate on a collateralized basis with similar terms, payments, and economic environments. The lease right-of-use (ROU) asset is determined based on the lease liability initially established and reduced for any prepaid lease payments and any lease incentives. We account for the lease and non-lease components of operating and finance lease contract consideration as a single lease component. Certain of the operating lease agreements contain rent concession, rent escalation, and option to renew provisions. Rent concession and rent escalation provisions are considered in determining the lease cost. Lease cost under our operating leases is recognized on a straight-line basis over the lease term commencing on the date we have the right to use the leased property. For finance leases, we recognize amortization expense of the finance lease ROU asset on a straight-line basis over the shorter of its useful life or lease term and record interest expense for finance lease liabilities based on the incremental borrowing rate. We generally use the base, non-cancelable, lease term when recognizing the lease assets and liabilities, unless it is reasonably certain that an extension or termination option will be exercised. Assets recognized and the short and long-term lease liabilities from finance leases are included in property and equipment, net, accrued expenses and other liabilities and other liabilities, non-current in the consolidated balance sheets. In addition, certain of our operating lease agreements contain tenant improvement allowances from our landlords. These allowances are accounted for as lease incentives and reduce our ROU asset and lease cost over the lease term. For short-term leases (defined as leases that, at the commencement date, have a lease term of twelve months or less, and do not include an option to purchase the underlying asset that we are reasonably certain to exercise), we recognize rent expense in our consolidated statements of operations on a straight-line basis over the lease term and record variable lease payments as incurred. |
Deferred Revenue and Revenue Recognition | Deferred Revenue Deferred revenue primarily consists of amounts that have been invoiced but have not yet been recognized as revenue and performance obligations pertaining to subscription services. The current portion of deferred revenue represents the amounts that are expected to be recognized as revenue within one year of the consolidated balance sheet dates. Revenue Recognition We generate revenue from two sources: (1) product revenue which includes the sale of integrated storage hardware and embedded licensed operating system software and (2) subscription services revenue which includes our portfolio of Evergreen offerings and Portworx . Subscription services revenue also include our professional services offerings such as installation and implementation consulting services. We typically recognize product revenue upon transfer of control to our customers and the satisfaction of our performance obligations. For Evergreen//Flex , product revenue is recognized upon the commencement of the underlying subscription services. Products are typically shipped directly by us to customers. Our subscription services revenue is derived from the services we perform in connection with the sale of subscription services and is recognized ratably over the contractual term, which generally ranges from one Evergreen subscription service agreement, which typically commences upon transfer of control of the corresponding products to our customers. Costs for subscription services are expensed when incurred. In addition, our Evergreen subscription provides our customers with a new controller based upon certain contractual terms. The controller refresh represents a separate performance obligation that is included within the Evergreen subscription service agreement and the allocated revenue is recognized upon shipment of the controller . Our Evergreen subscription services also include the right to receive unspecified software updates and upgrades on a when-and-if-available basis, software bug fixes, replacement parts and other services related to the underlying infrastructure, as well as access to our cloud-based management and support platform. We also sell professional services such as installation and implementation consulting services and the related revenue is recognized as services are performed. We recognize revenue upon the transfer of promised goods or services to customers in an amount that reflects the consideration we expect to be entitled in exchange for those goods or services. This is achieved through applying the following five-step approach: • Identification of the contract, or contracts, with a customer • Identification of the performance obligations in the contract • Determination of the transaction price • Allocation of the transaction price to the performance obligations in the contract • Recognition of revenue when, or as, we satisfy a performance obligation When applying this five-step approach, we apply judgment in determining the customer's ability and intention to pay, which is based on a variety of factors including the customer's historical payment experience and/or published credit and financial information pertaining to the customer. To the extent a customer contract includes multiple promised goods or services, we determine whether promised goods or services should be accounted for as a separate performance obligation. The transaction price is determined based on the consideration which we will be entitled to in exchange for transferring goods or services to the customer. For contracts that contain multiple performance obligations, we allocate the transaction price to each performance obligation based on a relative standalone selling price (SSP). The SSP is determined based on the price at which the performance obligation is sold separately, or if not observable through past transactions, is estimated taking into account available information such as market conditions and internally approved pricing guidelines related to performance obligations. |
Warranty | Warranty We generally provide a three-year warranty on hardware and a 90-day warranty on our software embedded in the hardware. Our hardware warranty provides for parts replacement for defective components and our software warranty provides for bug fixes. Our Evergreen subscription agreement provides for the same parts replacement that customers are entitled to under our warranty program, except that replacement parts are delivered according to targeted response times to minimize disruption to our customers’ critical business applications. Substantially all customers purchase Evergreen |
Research and Development | Research and DevelopmentResearch and development costs are expensed as incurred. Research and development costs consist primarily of employee compensation and related expenses, prototype expenses, to the extent there is no alternative use for that equipment, depreciation of equipment used in research and development, third-party engineering and contractor support costs, data center and cloud services costs as well as allocated overhead costs. |
Capitalized Internal-Use Software Costs | Capitalized Internal-Use Software Costs We expense costs to develop software that is externally marketed before technological feasibility is reached. We have determined that technological feasibility is reached shortly before the release of our products and as a result, the development costs incurred after the establishment of technological feasibility and before the release of those products have not been significant and accordingly, all related software development costs have been expensed as incurred. We capitalize (i) costs incurred to develop or modify software solely for our internal use, including hosted applications used to deliver our support services, and (ii) certain implementation costs incurred in a hosting arrangement that is a service contract when the preliminary project stage is complete, management with the relevant authority authorizes and commits to the funding of the software project, and it is probable the project will be completed and used to perform the intended function. Costs related to preliminary project activities and post implementation activities are expensed as incurred. Software development costs are capitalized to property, plant and equipment and amortized using the straight-line method over an estimated useful life of four years. Software development costs capitalized to property and equipment were $7.8 million and $7.3 million for fiscal 2022 and 2023. Amortization expense for software development costs was none during fiscal 2021 and 2022 and $2.2 million during fiscal 2023. Software implementation costs are capitalized to either prepaid and other current assets or other assets, non-current on our consolidated balance sheet and amortized over the terms of the associated hosting arrangements. Software implementation costs capitalized were $3.5 million and $9.3 million for fiscal 2022 and 2023. Amortization expense for software implementation costs was $0.1 million, $0.5 million and $1.5 million during fiscal 2021, 2022 and 2023. |
Advertising Expenses | Advertising ExpensesAdvertising costs are expensed as incurred. |
Stock-Based Compensation | Stock-Based Compensation Stock-based compensation includes expenses related to restricted stock units (RSUs), performance restricted stock units (PRSUs), restricted stock, stock options and purchase rights issued to employees under our employee stock purchase plan (ESPP). RSUs, PRSUs and restricted stock are measured at the fair market value of the underlying stock at the grant date. We determine the fair value of purchase rights issued to employees under our ESPP and our stock options under our equity plans on the date of grant utilizing the Black-Scholes option pricing model, which is impacted by the fair value of our common stock, as well as changes in assumptions regarding a number of subjective variables. These variables include the expected common stock price volatility over the term of the awards, the expected term of the awards, risk-free interest rates and expected dividend yield. We recognize stock-based compensation expense for stock-based awards with only service conditions on a straight-line basis over the period during which an employee is required to provide services in exchange for the award (generally the vesting period of the award). We account for forfeitures as they occur. For stock-based awards granted to employees with a performance condition, we recognize stock-based compensation expense for these awards under the accelerated attribution method over the requisite service period when management determines it is probable that the performance condition will be satisfied. |
Income Taxes | Income Taxes We account for income taxes using the asset and liability method. Deferred income taxes are recognized by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The measurement of deferred tax assets is reduced, if necessary, by a valuation allowance to amounts that are more likely than not to be realized. We recognize tax benefits from uncertain tax positions only if we believe that it is more likely than not that the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized in the financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. |
Recently Adopted Accounting Pronouncements and Recent Accounting Pronouncements | Recently Adopted Accounting Pronouncement In August 2020, the FASB issued ASU 2020-06, A ccounting for Convertible Instruments and Contracts in an Entity's Own Equity , which simplifies the accounting for certain convertible instruments, amends guidance on derivative scope exceptions for contracts in an entity's own equity, and requires the use of the if-converted method to calculate the impact of convertible instruments on diluted earnings per share (EPS) which results in the inclusion of the effect of share settlement for instruments that may be settled in cash or shares. We adopted this standard as of February 7, 2022 using the modified retrospective basis, under which financial results reported in prior periods were not adjusted. Adoption resulted in an adjustment of $133.3 million to reclassify the remaining balance of the conversion feature recorded in additional paid-in capital to the Notes of $35.2 million and accumulated deficit of $98.1 million on the consolidated balance sheet. Accordingly, we no longer carry an equity component of the Notes. For further information, see Note 7, Debt, and Note 13, Net Income (Loss) per Share Attributable to Common Stockholders. Recent Accounting Pronouncements There are no recently issued accounting pronouncements that are expected to have material impact on our consolidated financial statements and accompanying disclosures. |
Fair Value Measurements | Fair Value Measurements We define fair value as the exchange price that would be received from sale of an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. We measure our financial assets and liabilities at fair value at each reporting period using a fair value hierarchy which requires us to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Three levels of inputs may be used to measure fair value: • Level 1 - Observable inputs are unadjusted quoted prices in active markets for identical assets or liabilities; • Level 2 - Observable inputs are quoted prices for similar assets and liabilities in active markets or inputs other than quoted prices that are observable for the assets or liabilities, either directly or indirectly through market corroboration, for substantially the full term of the financial instruments; and • Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. These inputs are based on our own assumptions used to measure assets and liabilities at fair value and require significant management judgment or estimation. |
Basis of Presentation and Sum_3
Basis of Presentation and Summary of Significant Accounting Policies (Tables) | 12 Months Ended |
Feb. 05, 2023 | |
Accounting Policies [Abstract] | |
Schedule of Changes in Allowance for Doubtful Accounts | The following table presents the changes in the allowance for doubtful accounts: Fiscal Year Ended 2021 2022 2023 (in thousands) Allowance for doubtful accounts, beginning balance $ 542 $ 1,033 $ 945 Provision, net of cash received 496 (18) 377 Write-offs (5) (70) (265) Allowance for doubtful accounts, ending balance $ 1,033 $ 945 $ 1,057 |
Financial Instruments (Tables)
Financial Instruments (Tables) | 12 Months Ended |
Feb. 05, 2023 | |
Investments, Debt and Equity Securities [Abstract] | |
Schedule of Cash Equivalents, Marketable Securities and Restricted Cash | The following tables summarize our cash equivalents, marketable securities and restricted cash by significant investment categories and their classification within the fair value hierarchy at the end of fiscal 2022 and 2023 (in thousands): At the End of Fiscal 2022 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Cash Equivalents Marketable Securities Restricted Cash Level 1 Money market accounts $ — $ — $ — $ 29,275 $ 18,731 $ — $ 10,544 Level 2 U.S. government treasury notes 336,303 512 (2,176) 334,639 — 334,639 — U.S. government agencies 49,153 49 (193) 49,009 — 49,009 — Corporate debt securities 491,728 384 (4,731) 487,381 200 487,181 — Foreign government bonds 12,333 37 (17) 12,353 — 12,353 — Asset-backed securities 60,361 111 (453) 60,019 — 60,019 — Municipal bonds 3,950 — (78) 3,872 — 3,872 — Total $ 953,828 $ 1,093 $ (7,648) $ 976,548 $ 18,931 $ 947,073 $ 10,544 At the End of Fiscal 2023 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Cash Equivalents Marketable Securities Restricted Cash Level 1 Money market accounts $ — $ — $ — $ 49,733 $ 39,189 $ — $ 10,544 Level 2 U.S. government treasury notes 425,977 170 (4,229) 421,918 32,008 389,910 — U.S. government agencies 23,795 — (289) 23,506 — 23,506 — Corporate debt securities 527,164 901 (9,300) 518,765 — 518,765 — Foreign government bonds 4,797 — (44) 4,753 — 4,753 — Asset-backed securities 61,371 281 (1,016) 60,636 — 60,636 — Municipal bonds 3,950 — (168) 3,782 — 3,782 — Total $ 1,047,054 $ 1,352 $ (15,046) $ 1,083,093 $ 71,197 $ 1,001,352 $ 10,544 |
Schedule of Amortized Cost and Estimated Fair Value | The amortized cost and estimated fair value of our marketable securities are shown below by contractual maturity (in thousands): At the End of Fiscal 2023 Amortized Cost Fair Value Due within one year $ 542,675 $ 537,272 Due in one to five years 468,427 460,091 Due in five to ten years 3,944 3,989 Total $ 1,015,046 $ 1,001,352 |
Schedule of Gross Unrealized Losses and Fair Values | The following table presents gross unrealized losses and fair values for those investments that were in a continuous unrealized loss position at the end of fiscal 2022 and 2023, aggregated by investment category (in thousands): At the End of Fiscal 2022 Less than 12 months Greater than 12 months Total Fair Value Unrealized Loss Fair Value Unrealized Loss Fair Value Unrealized Loss U.S. government treasury notes $ 193,359 $ (2,176) $ — $ — $ 193,359 $ (2,176) U.S. government agencies 24,388 (193) — — 24,388 (193) Corporate debt securities 374,223 (4,708) 1,182 (23) 375,405 (4,731) Foreign government bonds 4,098 (17) — — 4,098 (17) Asset-backed securities 37,608 (453) — — 37,608 (453) Municipal bonds 3,872 (78) — — 3,872 (78) Total $ 637,548 $ (7,625) $ 1,182 $ (23) $ 638,730 $ (7,648) At the End of Fiscal 2023 Less than 12 months Greater than 12 months Total Fair Value Unrealized Loss Fair Value Unrealized Loss Fair Value Unrealized Loss U.S. government treasury notes $ 250,046 $ (130) $ 127,976 $ (4,099) $ 378,022 $ (4,229) U.S. government agencies 5,194 (5) 18,312 (284) 23,506 (289) Corporate debt securities 99,446 (330) 277,717 (8,970) 377,163 (9,300) Foreign government bonds 3,200 (5) 551 (39) 3,751 (44) Asset-backed securities 3,060 (25) 22,221 (991) 25,281 (1,016) Municipal bonds — — 3,782 (168) 3,782 (168) Total $ 360,946 $ (495) $ 450,559 $ (14,551) $ 811,505 $ (15,046) |
Business Combination (Tables)
Business Combination (Tables) | 12 Months Ended |
Feb. 05, 2023 | |
Business Combination and Asset Acquisition [Abstract] | |
Schedule of Consideration Transferred | The total purchase consideration for the acquisition of Portworx was $352.9 million, which consisted of the following (in thousands): Cash $ 344,049 Fair value of options assumed 8,802 Total $ 352,851 |
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed | The following table summarizes the fair values of assets acquired and liabilities assumed as of the date of the acquisition (in thousands): Amount Estimated Useful Life Goodwill $ 321,152 Identified intangible assets: Developed technology 21,273 5 years Customer relationships 6,459 7 years Trade name 3,623 3 years Cash 4,407 Net liabilities assumed (4,063) Total $ 352,851 |
Balance Sheet Components (Table
Balance Sheet Components (Tables) | 12 Months Ended |
Feb. 05, 2023 | |
Balance Sheet Components Disclosure [Abstract] | |
Schedule of Inventory | Inventory consists of the following (in thousands): At the End of Fiscal 2022 2023 Raw materials $ 15,734 $ 24,896 Finished goods 23,208 25,256 Inventory $ 38,942 $ 50,152 |
Schedule of Property and Equipment, Net | Property and equipment, net consists of the following (in thousands): At the End of Fiscal 2022 2023 Test equipment $ 266,672 $ 315,290 Computer equipment and software 206,053 262,574 Furniture and fixtures 8,652 9,693 Leasehold improvements 47,443 71,235 Capitalized software development costs 8,528 15,806 Total property and equipment 537,348 674,598 Less: accumulated depreciation and amortization (342,066) (402,153) Property and equipment, net $ 195,282 $ 272,445 |
Schedule of Intangible Assets, Net | Intangible assets, net consist of the following (in thousands): At the End of Fiscal 2022 2023 Gross Carrying Value Accumulated Amortization Net Carrying Amount Gross Carrying Value Accumulated Amortization Net Carrying Amount Technology patents $ 19,125 $ (13,544) $ 5,581 $ 19,125 $ (14,826) $ 4,299 Developed technology 80,166 (30,304) 49,862 83,211 (43,366) 39,845 Customer relationships 6,459 (1,246) 5,213 6,459 (2,166) 4,293 Trade name 3,623 (1,633) 1,990 3,623 (2,838) 785 Intangible assets, net $ 109,373 $ (46,727) $ 62,646 $ 112,418 $ (63,196) $ 49,222 |
Schedule of Expected Amortization Expenses for Intangible Assets | At the end of fiscal 2023, future expected amortization expense for intangible assets is as follows (in thousands): Fiscal Years Ending Future Expected 2024 $ 16,210 2025 15,425 2026 12,830 2027 3,107 2028 1,054 Thereafter 596 Total $ 49,222 |
Schedule of Goodwill | The change in the carrying amount of goodwill is as follows (in thousands): Amount Balance as of the end of fiscal 2022 $ 358,736 Goodwill acquired 2,691 Balance as of the end of fiscal 2023 $ 361,427 |
Schedule of Accrued Expenses and Other Liabilities | Accrued expenses and other liabilities consist of the following (in thousands): At the End of Fiscal 2022 2023 Taxes payable $ 6,312 $ 16,615 Accrued marketing 13,257 14,228 Accrued cloud and outside services 6,135 7,644 Supply chain-related accruals (1) 6,991 23,545 Accrued service logistics and professional services 6,244 7,927 Acquisition earn-out and deferred consideration 5,211 3,556 Finance lease liabilities, current 1,035 5,432 Customer deposits from contracts with customers 10,409 17,824 Other accrued liabilities 22,917 26,978 Total accrued expenses and other liabilities $ 78,511 $ 123,749 _________________________________ (1) Primarily consist of warranty reserves and accruals related to our inventory and inventory purchase commitments with our contract manufacturers. |
Deferred Revenue and Commissi_2
Deferred Revenue and Commissions (Tables) | 12 Months Ended |
Feb. 05, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Schedule of Deferred Commissions | Changes in total deferred commissions during the periods presented are as follows (in thousands): Fiscal Year Ended 2022 2023 Beginning balance $ 187,924 $ 246,307 Additions 217,595 155,414 Recognition of deferred commissions (159,212) (155,865) Ending balance $ 246,307 $ 245,856 |
Schedule of Deferred Revenue | Changes in total deferred revenue during the periods presented are as follows (in thousands): Fiscal Year Ended 2022 2023 Beginning balance $ 843,697 $ 1,079,872 Additions 937,510 1,248,417 Recognition of deferred revenue (701,335) (942,639) Ending balance $ 1,079,872 $ 1,385,650 |
Debt (Tables)
Debt (Tables) | 12 Months Ended |
Feb. 05, 2023 | |
Debt Disclosure [Abstract] | |
Schedule of Convertible Debt | The Notes consisted of the following (in thousands): At the End of Fiscal 2022 2023 Liability: Principal $ 575,000 $ 575,000 Less: debt discount, net of amortization (1) (35,641) — Less: debt issuance costs, net of amortization (1) (2,580) (494) Net carrying amount of the Notes $ 536,779 $ 574,506 Stockholders' equity recorded at issuance: Allocated value of the conversion feature (1) $ 136,333 $ — Less: debt issuance costs (1) (3,068) — Additional paid-in capital $ 133,265 $ — _________________________________ (1) Fiscal 2023 reflects the adoption of ASU 2020-06 on February 7, 2022 using the modified retrospective method as described in Note 2. |
Schedule of Interest Expense | The following table sets forth total interest expense recognized related to the Notes (in thousands): Fiscal Year Ended 2022 2023 Amortization of debt discount (1) $ 28,874 $ — Amortization of debt issuance costs (1) 2,091 2,598 Total amortization of debt discount and debt issuance costs 30,965 2,598 Contractual interest expense 732 716 Total interest expense related to the Notes $ 31,697 $ 3,314 Effective interest rate of the liability component 5.6 % 0.6 % _________________________________ (1) Fiscal 2023 reflects the adoption of ASU 2020-06 on February 7, 2022 using the modified retrospective method as described in Note 2. |
Leases (Tables)
Leases (Tables) | 12 Months Ended |
Feb. 05, 2023 | |
Leases [Abstract] | |
Components of Lease Cost | The components of lease costs were as follows (in thousands): Fiscal Year Ended 2021 2022 2023 Fixed operating lease cost $ 37,411 $ 37,598 $ 47,533 Variable lease cost (1) 9,168 10,228 8,521 Short-term lease cost (12 months or less) 5,734 4,178 3,787 Finance lease cost: Amortization of finance lease right-of-use assets — 384 3,028 Interest on finance lease liabilities — 42 330 Total finance lease cost $ — $ 426 $ 3,358 Total lease cost $ 52,313 $ 52,430 $ 63,199 _________________________________ (1) Variable lease cost predominantly included common area maintenance charges. Supplemental information related to leases is as follows (in thousands): Fiscal Year Ended 2022 2023 Operating leases: Weighted-average remaining lease term (in years) 4.5 5.2 Weighted-average discount rate 5.7 % 6.1 % Finance leases: Finance lease right-of-use assets, gross (1) $ 3,577 $ 17,596 Accumulated amortization (1) (384) (3,412) Finance lease right-of-use assets, net (1) $ 3,193 $ 14,184 Finance lease liabilities, current (2) 1,035 5,432 Finance lease liabilities, non-current (3) 1,487 4,765 Total finance lease liabilities $ 2,522 $ 10,197 Weighted-average remaining lease term (in years) 3.6 3.3 Weighted-average discount rate 2.7 % 5.1 % ____________________________________ (1) Included in the consolidated balance sheets within property and equipment, net. (2) Included in the consolidated balance sheets within accrued expenses and other liabilities (3) Included in the consolidated balance sheets within other liabilities, non-current |
Schedule of Cash Flow, Supplemental Disclosures | Supplemental cash flow information related to leases is as follows (in thousands): Fiscal Year Ended 2022 2023 Cash paid for amounts included in the measurement of lease liabilities: Operating cash outflows for operating leases $ 36,648 $ 49,955 Financing cash outflows for finance leases $ 1,000 $ 6,138 Right-of-use assets obtained in exchange for lease liabilities: Operating leases $ 7,517 $ 80,962 Finance leases $ 3,577 $ 14,019 |
Schedule of Future Lease Payments Under Non-Cancelable Leases | Future lease payments under our non-cancelable leases at the end of fiscal 2023 are as follows (in thousands): Fiscal Years Ending Operating Leases Finance Leases 2024 $ 45,153 $ 5,839 2025 48,315 4,728 2026 36,366 183 2027 19,384 — 2028 21,062 — Thereafter 44,274 — Total future lease payments $ 214,554 $ 10,750 Less: imputed interest (38,374) (553) Present value of total lease liabilities $ 176,180 $ 10,197 |
Stockholders' Equity (Tables)
Stockholders' Equity (Tables) | 12 Months Ended |
Feb. 05, 2023 | |
Equity [Abstract] | |
Summary of Reserved Shares of Common Stock for Future Issuance | At the end of fiscal 2023, we had reserved shares of common stock for future issuance as follows: Shares underlying outstanding stock options 9,268,498 Shares underlying outstanding restricted stock units 26,760,520 Shares reserved for future equity awards 20,661,582 Shares reserved for future employee stock purchase plan awards 5,309,812 Total 62,000,412 |
Equity Incentive Plans (Tables)
Equity Incentive Plans (Tables) | 12 Months Ended |
Feb. 05, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Summary of Stock Option Activity Under Equity Incentive Plans and Related Information | A summary of the stock option activity under our equity incentive plans and related information is as follows: Options Outstanding Number of Weighted- Weighted- Aggregate Balance at the end of fiscal 2022 12,268,938 $ 10.25 3.5 $ 198,266 Options exercised (2,988,068) 8.29 Options forfeited (12,372) 1.83 Balance at the end of fiscal 2023 9,268,498 $ 10.90 2.7 $ 176,674 Vested and exercisable at the end of fiscal 2023 9,077,014 $ 11.04 2.6 $ 171,315 |
Summary of Estimate Fair Value of Employee Stock Options and Employee Purchase Plan | The assumptions used for the periods presented are as follows: Fiscal Year Ended 2021 2022 2023 Employee Stock Options Expected term (in years) 5.65 n/a n/a Expected volatility 52.07% n/a n/a Risk-free interest rate 0.3% n/a n/a Dividend rate — n/a n/a Fair value of common stock $15.79 n/a n/a Employee Stock Purchase Plan Expected term (in years) 0.5 - 2.0 0.5 - 2.0 0.5 - 2.0 Expected volatility 52% - 113% 44% - 61% 45% - 54% Risk-free interest rate 0.1% - 0.4% 0.1% - 0.2% 0.9% - 4.0% Dividend rate — — — Fair value of common stock $9.07 - $15.26 $23.63 - $26.69 $28.73 - $31.68 |
Schedule of Share-based Compensation, Restricted Stock Units Award Activity | A summary of the RSU and PRSU activity under our equity incentive plans and related information is as follows: Number of RSUs and PRSUs Outstanding Weighted-Average Grant Date Fair Value Aggregate Intrinsic Value Unvested balance at the end of fiscal 2022 28,712,878 $ 19.53 $ 757,446 Granted 15,319,768 29.67 Vested (13,915,802) 20.05 Forfeited (3,356,324) 21.75 Unvested balance at the end of fiscal 2023 26,760,520 $ 24.78 $ 800,407 |
Schedule of Restricted Stock Activity | A summary of the restricted stock activity under our 2015 Plan and related information is as follows: Number of Restricted Stock Outstanding Weighted- Aggregate Unvested balance at the end of fiscal 2022 54,977 $ 20.02 $ 1,450 Vested (54,977) 20.02 Forfeited — — Unvested balance at the end of fiscal 2023 — $ — $ — |
Summarizes the Components of Stock-Based Compensation | The following table summarizes the components of stock-based compensation expense recognized in the consolidated statements of operations (in thousands): Fiscal Year Ended 2021 2022 2023 Cost of revenue—product $ 4,001 $ 6,334 $ 10,245 Cost of revenue—subscription services 14,979 21,240 22,630 Research and development 117,220 142,264 161,694 Sales and marketing 65,248 71,439 72,507 General and administrative 40,896 45,686 60,541 Total stock-based compensation expense $ 242,344 $ 286,963 $ 327,617 |
Net Income (Loss) per Share A_2
Net Income (Loss) per Share Attributable to Common Stockholders (Tables) | 12 Months Ended |
Feb. 05, 2023 | |
Earnings Per Share [Abstract] | |
Summary of Computation of Basic and Diluted Net Income (Loss) per Share Attributable to Common Stockholders | The following table sets forth the computation of basic and diluted net income (loss) per share attributable to common stockholders (in thousands, except per share data): Fiscal Year Ended 2021 2022 2023 Numerator: Net income (loss) attributable to common stockholders, basic $ (282,076) $ (143,259) $ 73,071 Add: Interest charges related to our Notes — — 3,314 Net income (loss) attributable to common stockholders, diluted $ (282,076) $ (143,259) $ 76,385 Denominator: Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, basic 267,824 285,882 299,478 Add: Dilutive effect of common stock equivalents — — 39,706 Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, diluted 267,824 285,882 339,184 Net income (loss) per share attributable to common stockholders, basic $ (1.05) $ (0.50) $ 0.24 Net income (loss) per share attributable to common stockholders, diluted $ (1.05) $ (0.50) $ 0.23 |
Summary of Weighted-average Outstanding Shares Excluded from Computation of Diluted Net Income (Loss) per Share Attributable to Common Stockholders | The following weighted-average outstanding shares of common stock equivalents were excluded from the computation of diluted net income (loss) per share attributable to common stockholders for the periods presented because including them would have been anti-dilutive (in thousands): Fiscal Year Ended 2021 2022 2023 Stock options to purchase common stock 23,180 15,686 10,516 Unvested RSUs and PRSUs 31,980 32,491 29,780 Unvested restricted stock 1,145 257 6 Shares related to convertible senior notes 21,884 21,884 — Shares issuable pursuant to the ESPP 2,148 2,122 885 Total 80,337 72,440 41,187 |
Other Income (Expense), Net (Ta
Other Income (Expense), Net (Tables) | 12 Months Ended |
Feb. 05, 2023 | |
Other Income and Expenses [Abstract] | |
Summary of Other Income (Expense) | Other income (expense), net consists of the following (in thousands): Fiscal Year Ended 2021 2022 2023 Interest income (1) $ 17,442 $ 9,371 $ 17,320 Interest expense (2) (31,403) (36,677) (4,749) Foreign currency transactions gains (losses) 2,507 (5,235) (8,345) Other income 2,327 2,443 4,069 Total other income (expense), net $ (9,127) $ (30,098) $ 8,295 _________________________________ (1) Interest income includes interest income related to our cash, cash equivalents and marketable securities and non-cash interest income (expense) related to accretion (amortization) of the discount (premium) on marketable securities. (2) Interest expense includes non-cash interest expense related to amortization of debt discount and debt issuance costs, contractual interest expense related to our debt and accretion of our finance lease liabilities. |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Feb. 05, 2023 | |
Income Tax Disclosure [Abstract] | |
Schedule Of Geographical Breakdown Of Income (Loss) Before Provision For Income Taxes | The geographical breakdown of income (loss) before provision for income taxes is as follows (in thousands): Fiscal Year Ended 2021 2022 2023 Domestic $ (312,119) $ (192,058) $ 39,004 International 41,959 63,562 52,804 Total $ (270,160) $ (128,496) $ 91,808 |
Schedule of Components of Provision for Income Taxes | The components of the provision for income taxes are as follows (in thousands): Fiscal Year Ended 2021 2022 2023 Current: State $ 442 $ 592 $ 5,999 Foreign 8,006 12,525 12,020 Total $ 8,448 $ 13,117 $ 18,019 Deferred: Federal $ (218) $ — $ (639) State — — (99) Foreign 3,686 1,646 1,456 Total $ 3,468 $ 1,646 $ 718 Provision for income taxes $ 11,916 $ 14,763 $ 18,737 |
Schedule of Reconciliation of the Federal Statutory Income Tax Rate and Effective Income Tax Rate | The reconciliation of income taxes at the federal statutory income tax rate to the provision for income taxes is as follows (in thousands): Fiscal Year Ended 2021 2022 2023 Tax at federal statutory rate $ (56,734) $ (26,984) $ 19,280 State tax, net of federal benefit 349 468 4,625 Stock-based compensation expense (604) (19,658) (11,976) Research and development tax credits (14,138) (16,783) (26,634) U.S. taxes on foreign income 14,021 25,059 19,065 Foreign rate differential 2,282 (1,698) (425) Withholding tax 34 143 2,339 Change in valuation allowance 63,146 48,270 10,631 Non-deductible expenses — 4,381 2,091 Other 3,560 1,565 (259) Provision for income taxes $ 11,916 $ 14,763 $ 18,737 |
Significant Components of Deferred Tax Assets and Liabilities | The significant components of our deferred tax assets and liabilities were as follows (in thousands): At the End of Fiscal 2022 2023 Deferred tax assets: Net operating loss carryforwards $ 369,904 $ 198,495 Tax credit carryover 134,085 171,775 Accruals and reserves 22,625 34,506 Deferred revenue 66,242 87,026 Stock-based compensation expense 25,247 25,564 ASC 842 lease liabilities 28,577 40,772 Capitalized research and development — 154,027 Other 1,879 4,950 Total deferred tax assets $ 648,559 $ 717,115 Valuation allowance (554,553) (598,997) Total deferred tax assets, net of valuation allowance $ 94,006 $ 118,118 Deferred tax liabilities: Depreciation and amortization $ (12,992) $ (31,744) Deferred commissions (53,219) (53,421) Convertible debt (4,642) — ASC 842 right-of-use assets (24,608) (36,366) Acquired intangibles and goodwill (6,850) (4,702) Interest income (874) (2,521) Total deferred tax liabilities $ (103,185) $ (128,754) Net deferred tax liabilities $ (9,179) $ (10,636) |
Summary of Activity Related to Unrecognized Tax Benefits | The activity related to the unrecognized tax benefits is as follows (in thousands): Fiscal Year Ended 2021 2022 2023 Gross unrecognized tax benefits—beginning balance $ 28,570 $ 39,571 $ 51,582 Decreases related to tax positions taken during prior years (345) (173) — Increases related to tax positions taken during prior years 1,881 1,201 2,172 Increases related to tax positions taken during current year 9,465 10,983 15,143 Gross unrecognized tax benefits—ending balance $ 39,571 $ 51,582 $ 68,897 |
Segment Information (Tables)
Segment Information (Tables) | 12 Months Ended |
Feb. 05, 2023 | |
Segment Reporting [Abstract] | |
Schedule of Revenue by Geographic Area | The following table depicts the disaggregation of revenue by geographic area based on the billing address of our customers and is consistent with how we evaluate our financial performance (in thousands): Fiscal Year Ended 2021 2022 2023 United States $ 1,195,428 $ 1,580,022 $ 1,971,757 Rest of the world 488,751 600,826 781,677 Total revenue $ 1,684,179 $ 2,180,848 $ 2,753,434 |
Schedule of Long-Lived Assets by Geographic Area | Long-lived assets, which are comprised of property and equipment, net, by geographic area are summarized as follows (in thousands): At the End of Fiscal 2022 2023 United States $ 187,228 $ 259,131 Rest of the world 8,054 13,314 Total long-lived assets $ 195,282 $ 272,445 |
Basis of Presentation and Sum_4
Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details) | 3 Months Ended | 12 Months Ended | |||
Feb. 07, 2022 USD ($) | May 02, 2021 | Feb. 05, 2023 USD ($) financialInstitution revenueSource | Feb. 06, 2022 USD ($) | Jan. 31, 2021 USD ($) | |
Concentration Risk [Line Items] | |||||
Number of financial institutions where deposits exceed federally insured limits | financialInstitution | 2 | ||||
Restricted cash | $ 10,544,000 | $ 10,544,000 | $ 10,544,000 | ||
Depreciation and amortization | $ 100,432,000 | 83,151,000 | 70,042,000 | ||
Useful life of deferred commissions related to subscription services revenue | 6 years | ||||
Number of revenue sources | revenueSource | 2 | ||||
Warranty reserve | $ 7,400,000 | ||||
Capitalized software, amortization | 1,500,000 | 500,000 | 100,000 | ||
Advertising expenses | 11,100,000 | 15,300,000 | 8,100,000 | ||
Reduce in additional paid-in capital | $ 133,300,000 | ||||
Debt instrument increase net | 35,200,000 | ||||
Accumulated deficit | $ 98,100,000 | 1,537,062,000 | 1,708,271,000 | ||
Property, Plant and Equipment | |||||
Concentration Risk [Line Items] | |||||
Software development costs capitalized during the period | 7,300,000 | 7,800,000 | |||
Capitalized software, amortization | 2,200,000 | 0 | 0 | ||
Other Assets | |||||
Concentration Risk [Line Items] | |||||
Software development costs capitalized during the period | $ 9,300,000 | $ 3,500,000 | |||
Hardware | |||||
Concentration Risk [Line Items] | |||||
Standard product warranty period | 3 years | ||||
Embedded Software | |||||
Concentration Risk [Line Items] | |||||
Standard product warranty period | 90 days | ||||
Change in accounting estimate | |||||
Concentration Risk [Line Items] | |||||
Depreciation and amortization | $ (23,600,000) | ||||
Minimum | |||||
Concentration Risk [Line Items] | |||||
Estimated useful life of intangible assets | 3 years | ||||
Maximum | |||||
Concentration Risk [Line Items] | |||||
Estimated useful life of intangible assets | 7 years | ||||
Test equipment | |||||
Concentration Risk [Line Items] | |||||
Property and equipment, useful life | 4 years | ||||
Computer equipment and software | Minimum | |||||
Concentration Risk [Line Items] | |||||
Property and equipment, useful life | 2 years | 4 years | |||
Computer equipment and software | Maximum | |||||
Concentration Risk [Line Items] | |||||
Property and equipment, useful life | 3 years | 5 years | |||
Furniture and fixtures | |||||
Concentration Risk [Line Items] | |||||
Property and equipment, useful life | 7 years | ||||
Test equipment, certain computer equipment and software | |||||
Concentration Risk [Line Items] | |||||
Property and equipment, useful life | 4 years | ||||
Software development costs | |||||
Concentration Risk [Line Items] | |||||
Property and equipment, useful life | 4 years | ||||
Customer concentration risk | Accounts receivable | 1 Channel Partner | |||||
Concentration Risk [Line Items] | |||||
Concentration risk percentage | 1,000% | ||||
Customer concentration risk | Accounts receivable | No Channel Partner or Customer | |||||
Concentration Risk [Line Items] | |||||
Concentration risk percentage | 1,000% | ||||
Customer concentration risk | Revenue | No Channel Partner or Customer | |||||
Concentration Risk [Line Items] | |||||
Concentration risk percentage | 1,000% | 1,000% | 1,000% |
Basis of Presentation and Sum_5
Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Changes in Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Feb. 05, 2023 | Feb. 06, 2022 | Jan. 31, 2021 | |
Allowance for Doubtful Accounts Receivable [Roll Forward] | |||
Allowance for doubtful accounts, beginning balance | $ 945 | $ 1,033 | $ 542 |
Provision, net of cash received | 377 | (18) | 496 |
Write-offs | (265) | (70) | (5) |
Allowance for doubtful accounts, ending balance | $ 1,057 | $ 945 | $ 1,033 |
Basis of Presentation and Sum_6
Basis of Presentation and Summary of Significant Accounting Policies - Revenue Recognition (Details) - Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-02-06 | Feb. 05, 2023 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue contractual term | 12 months |
Subscription Service Revenue | Minimum | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue contractual term | 1 year |
Subscription Service Revenue | Maximum | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue contractual term | 6 years |
Financial Instruments - Cash Eq
Financial Instruments - Cash Equivalents, Marketable Securities and Restricted Cash (Details) - USD ($) $ in Thousands | Feb. 05, 2023 | Feb. 06, 2022 |
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | $ 1,015,046 | |
Fair Value | 1,001,352 | |
Cash Equivalents | 71,197 | $ 18,931 |
Marketable securities | 1,001,352 | 947,073 |
Restricted Cash | 10,544 | 10,544 |
Amortized Cost | 1,047,054 | 953,828 |
Total gross unrealized gains | 1,352 | 1,093 |
Total gross unrealized losses | (15,046) | (7,648) |
Total fair value | 1,083,093 | 976,548 |
Level 1 | Money market accounts | ||
Debt Securities, Available-for-sale [Line Items] | ||
Fair Value | 49,733 | 29,275 |
Cash Equivalents | 39,189 | 18,731 |
Marketable securities | 0 | 0 |
Restricted Cash | 10,544 | 10,544 |
Level 2 | U.S. government treasury notes | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 425,977 | 336,303 |
Gross Unrealized Gains | 170 | 512 |
Gross Unrealized Losses | (4,229) | (2,176) |
Fair Value | 421,918 | 334,639 |
Cash Equivalents | 32,008 | 0 |
Marketable securities | 389,910 | 334,639 |
Restricted Cash | 0 | 0 |
Level 2 | U.S. government agencies | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 23,795 | 49,153 |
Gross Unrealized Gains | 0 | 49 |
Gross Unrealized Losses | (289) | (193) |
Fair Value | 23,506 | 49,009 |
Cash Equivalents | 0 | 0 |
Marketable securities | 23,506 | 49,009 |
Restricted Cash | 0 | 0 |
Level 2 | Corporate debt securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 527,164 | 491,728 |
Gross Unrealized Gains | 901 | 384 |
Gross Unrealized Losses | (9,300) | (4,731) |
Fair Value | 518,765 | 487,381 |
Cash Equivalents | 0 | 200 |
Marketable securities | 518,765 | 487,181 |
Restricted Cash | 0 | 0 |
Level 2 | Foreign government bonds | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 4,797 | 12,333 |
Gross Unrealized Gains | 0 | 37 |
Gross Unrealized Losses | (44) | (17) |
Fair Value | 4,753 | 12,353 |
Cash Equivalents | 0 | 0 |
Marketable securities | 4,753 | 12,353 |
Restricted Cash | 0 | 0 |
Level 2 | Asset-backed securities | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 61,371 | 60,361 |
Gross Unrealized Gains | 281 | 111 |
Gross Unrealized Losses | (1,016) | (453) |
Fair Value | 60,636 | 60,019 |
Cash Equivalents | 0 | 0 |
Marketable securities | 60,636 | 60,019 |
Restricted Cash | 0 | 0 |
Level 2 | Municipal bonds | ||
Debt Securities, Available-for-sale [Line Items] | ||
Amortized Cost | 3,950 | 3,950 |
Gross Unrealized Gains | 0 | 0 |
Gross Unrealized Losses | (168) | (78) |
Fair Value | 3,782 | 3,872 |
Cash Equivalents | 0 | 0 |
Marketable securities | 3,782 | 3,872 |
Restricted Cash | $ 0 | $ 0 |
Financial Instruments - Amortiz
Financial Instruments - Amortized Cost and Estimated Fair Value (Details) - USD ($) | 12 Months Ended | ||
Feb. 05, 2023 | Feb. 06, 2022 | Jan. 31, 2021 | |
Amortized Cost | |||
Due within one year | $ 542,675,000 | ||
Due in one to five years | 468,427,000 | ||
Due in five to ten years | 3,944,000 | ||
Amortized Cost | 1,015,046,000 | ||
Fair Value | |||
Due within one year | 537,272,000 | ||
Due in one to five years | 460,091,000 | ||
Due in five to ten years | 3,989,000 | ||
Total | 1,001,352,000 | ||
Impairment charge for unrealized losses | $ 0 | $ 0 | $ 0 |
Financial Instruments - Gross U
Financial Instruments - Gross Unrealized Losses and Fair Values (Details) - USD ($) $ in Thousands | Feb. 05, 2023 | Feb. 06, 2022 |
Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract] | ||
Fair Value, Less then 12 months | $ 360,946 | $ 637,548 |
Unrealized Loss, Less then 12 months | (495) | (7,625) |
Fair Value Greater then 12 months | 450,559 | 1,182 |
Unrealized Loss, Greater then 12 months | (14,551) | (23) |
Fair Value Total | 811,505 | 638,730 |
Unrealized Loss Total | (15,046) | (7,648) |
U.S. government treasury notes | ||
Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract] | ||
Fair Value, Less then 12 months | 250,046 | 193,359 |
Unrealized Loss, Less then 12 months | (130) | (2,176) |
Fair Value Greater then 12 months | 127,976 | 0 |
Unrealized Loss, Greater then 12 months | (4,099) | 0 |
Fair Value Total | 378,022 | 193,359 |
Unrealized Loss Total | (4,229) | (2,176) |
U.S. government agencies | ||
Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract] | ||
Fair Value, Less then 12 months | 5,194 | 24,388 |
Unrealized Loss, Less then 12 months | (5) | (193) |
Fair Value Greater then 12 months | 18,312 | 0 |
Unrealized Loss, Greater then 12 months | (284) | 0 |
Fair Value Total | 23,506 | 24,388 |
Unrealized Loss Total | (289) | (193) |
Corporate debt securities | ||
Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract] | ||
Fair Value, Less then 12 months | 99,446 | 374,223 |
Unrealized Loss, Less then 12 months | (330) | (4,708) |
Fair Value Greater then 12 months | 277,717 | 1,182 |
Unrealized Loss, Greater then 12 months | (8,970) | (23) |
Fair Value Total | 377,163 | 375,405 |
Unrealized Loss Total | (9,300) | (4,731) |
Foreign government bonds | ||
Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract] | ||
Fair Value, Less then 12 months | 3,200 | 4,098 |
Unrealized Loss, Less then 12 months | (5) | (17) |
Fair Value Greater then 12 months | 551 | 0 |
Unrealized Loss, Greater then 12 months | (39) | 0 |
Fair Value Total | 3,751 | 4,098 |
Unrealized Loss Total | (44) | (17) |
Asset-backed securities | ||
Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract] | ||
Fair Value, Less then 12 months | 3,060 | 37,608 |
Unrealized Loss, Less then 12 months | (25) | (453) |
Fair Value Greater then 12 months | 22,221 | 0 |
Unrealized Loss, Greater then 12 months | (991) | 0 |
Fair Value Total | 25,281 | 37,608 |
Unrealized Loss Total | (1,016) | (453) |
Municipal bonds | ||
Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract] | ||
Fair Value, Less then 12 months | 0 | 3,872 |
Unrealized Loss, Less then 12 months | 0 | (78) |
Fair Value Greater then 12 months | 3,782 | 0 |
Unrealized Loss, Greater then 12 months | (168) | 0 |
Fair Value Total | 3,782 | 3,872 |
Unrealized Loss Total | $ (168) | $ (78) |
Business Combination - Addition
Business Combination - Additional Information (Details) - Portworx - USD ($) shares in Millions | 1 Months Ended | ||
Oct. 31, 2020 | Feb. 05, 2023 | Jan. 31, 2021 | |
Business Acquisition [Line Items] | |||
Total purchase consideration | $ 352,851,000 | ||
Goodwill expected to be tax deductible | 0 | ||
Deferred tax assets, before valuation allowance | 14,700,000 | ||
Deferred tax assets, valuation allowance | 14,700,000 | ||
Deferred tax assets, net | $ 0 | ||
Transaction price contingent on continuous employment of founders | $ 32,200,000 | $ 4,900,000 | |
Transaction price contingent on continuous employment of founders, earnout period | 3 years | ||
Replacement Awards | |||
Business Acquisition [Line Items] | |||
Shares issued upon conversion of stock options (in shares) | 1.9 | ||
Equity interests issued and issuable | $ 26,800,000 | ||
Replacement Awards for Services Performed Prior to the Acquisition | |||
Business Acquisition [Line Items] | |||
Equity interests issued and issuable | 8,800,000 | ||
Replacement Awards for Future Services | |||
Business Acquisition [Line Items] | |||
Equity interests issued and issuable | 18,000,000 | ||
Unvested RSUs and PRSUs | |||
Business Acquisition [Line Items] | |||
Equity interests issued and issuable | $ 31,800,000 | ||
Outstanding awards assumed (in shares) | 2 | ||
Equity awards vesting period | 4 years |
Business Combination - Purchase
Business Combination - Purchase Consideration (Details) - USD ($) $ in Thousands | 1 Months Ended | 12 Months Ended | ||
Oct. 31, 2020 | Feb. 05, 2023 | Feb. 06, 2022 | Jan. 31, 2021 | |
Business Acquisition [Line Items] | ||||
Fair value of options assumed | $ 0 | $ 0 | $ 8,802 | |
Portworx | ||||
Business Acquisition [Line Items] | ||||
Cash | $ 344,049 | |||
Fair value of options assumed | 8,802 | |||
Total | $ 352,851 |
Business Combination - Net Asse
Business Combination - Net Assets Acquired (Details) - USD ($) $ in Thousands | 1 Months Ended | 12 Months Ended | |
Oct. 31, 2020 | Feb. 05, 2023 | Feb. 06, 2022 | |
Business Acquisition [Line Items] | |||
Goodwill | $ 361,427 | $ 358,736 | |
Developed technology | |||
Business Acquisition [Line Items] | |||
Estimated Useful Life | 3 years | ||
Customer relationships | |||
Business Acquisition [Line Items] | |||
Estimated Useful Life | 4 years 8 months 12 days | ||
Trade name | |||
Business Acquisition [Line Items] | |||
Estimated Useful Life | 7 months 6 days | ||
Portworx | |||
Business Acquisition [Line Items] | |||
Goodwill | $ 321,152 | ||
Cash | 4,407 | ||
Net liabilities assumed | (4,063) | ||
Total | 352,851 | ||
Portworx | Developed technology | |||
Business Acquisition [Line Items] | |||
Identified intangible assets: | $ 21,273 | ||
Estimated Useful Life | 5 years | ||
Portworx | Customer relationships | |||
Business Acquisition [Line Items] | |||
Identified intangible assets: | $ 6,459 | ||
Estimated Useful Life | 7 years | ||
Portworx | Trade name | |||
Business Acquisition [Line Items] | |||
Identified intangible assets: | $ 3,623 | ||
Estimated Useful Life | 3 years |
Balance Sheet Components - Inve
Balance Sheet Components - Inventory (Details) - USD ($) $ in Thousands | Feb. 05, 2023 | Feb. 06, 2022 |
Balance Sheet Components Disclosure [Abstract] | ||
Raw materials | $ 24,896 | $ 15,734 |
Finished goods | 25,256 | 23,208 |
Inventory | $ 50,152 | $ 38,942 |
Balance Sheet Components - Prop
Balance Sheet Components - Property and Equipment, Net (Details) - USD ($) $ in Thousands | Feb. 05, 2023 | Feb. 06, 2022 |
Property Plant And Equipment [Line Items] | ||
Total property and equipment | $ 674,598 | $ 537,348 |
Less: accumulated depreciation and amortization | (402,153) | (342,066) |
Property and equipment, net | 272,445 | 195,282 |
Test equipment | ||
Property Plant And Equipment [Line Items] | ||
Total property and equipment | 315,290 | 266,672 |
Computer equipment and software | ||
Property Plant And Equipment [Line Items] | ||
Total property and equipment | 262,574 | 206,053 |
Furniture and fixtures | ||
Property Plant And Equipment [Line Items] | ||
Total property and equipment | 9,693 | 8,652 |
Leasehold improvements | ||
Property Plant And Equipment [Line Items] | ||
Total property and equipment | 71,235 | 47,443 |
Capitalized software development costs | ||
Property Plant And Equipment [Line Items] | ||
Total property and equipment | $ 15,806 | $ 8,528 |
Balance Sheet Components - Addi
Balance Sheet Components - Additional Information (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Feb. 05, 2023 | Feb. 06, 2022 | Jan. 31, 2021 | |
Finite Lived Intangible Assets [Line Items] | |||
Depreciation and amortization | $ 87 | $ 65.9 | $ 57.1 |
Intangible assets amortization expense | $ 16.5 | $ 16.8 | $ 13 |
Technology patents | |||
Finite Lived Intangible Assets [Line Items] | |||
Estimated Useful Life | 1 year 7 months 6 days | ||
Developed technology | |||
Finite Lived Intangible Assets [Line Items] | |||
Estimated Useful Life | 3 years | ||
Customer relationships | |||
Finite Lived Intangible Assets [Line Items] | |||
Estimated Useful Life | 4 years 8 months 12 days | ||
Trade name | |||
Finite Lived Intangible Assets [Line Items] | |||
Estimated Useful Life | 7 months 6 days |
Balance Sheet Components - Inta
Balance Sheet Components - Intangible Assets, Net (Details) - USD ($) $ in Thousands | Feb. 05, 2023 | Feb. 06, 2022 |
Finite Lived Intangible Assets [Line Items] | ||
Gross Carrying Value | $ 112,418 | $ 109,373 |
Accumulated Amortization | (63,196) | (46,727) |
Net Carrying Amount | 49,222 | 62,646 |
Technology patents | ||
Finite Lived Intangible Assets [Line Items] | ||
Gross Carrying Value | 19,125 | 19,125 |
Accumulated Amortization | (14,826) | (13,544) |
Net Carrying Amount | 4,299 | 5,581 |
Developed technology | ||
Finite Lived Intangible Assets [Line Items] | ||
Gross Carrying Value | 83,211 | 80,166 |
Accumulated Amortization | (43,366) | (30,304) |
Net Carrying Amount | 39,845 | 49,862 |
Customer relationships | ||
Finite Lived Intangible Assets [Line Items] | ||
Gross Carrying Value | 6,459 | 6,459 |
Accumulated Amortization | (2,166) | (1,246) |
Net Carrying Amount | 4,293 | 5,213 |
Trade name | ||
Finite Lived Intangible Assets [Line Items] | ||
Gross Carrying Value | 3,623 | 3,623 |
Accumulated Amortization | (2,838) | (1,633) |
Net Carrying Amount | $ 785 | $ 1,990 |
Balance Sheet Components - Expe
Balance Sheet Components - Expected Amortization Expenses for Intangible Assets (Details) - USD ($) $ in Thousands | Feb. 05, 2023 | Feb. 06, 2022 |
Balance Sheet Components Disclosure [Abstract] | ||
2024 | $ 16,210 | |
2025 | 15,425 | |
2026 | 12,830 | |
2027 | 3,107 | |
2028 | 1,054 | |
Thereafter | 596 | |
Net Carrying Amount | $ 49,222 | $ 62,646 |
Balance Sheet Components - Good
Balance Sheet Components - Goodwill (Details) - USD ($) | 12 Months Ended | |
Feb. 05, 2023 | Feb. 06, 2022 | |
Goodwill | ||
Goodwill, beginning balance | $ 358,736,000 | |
Goodwill acquired | 2,691,000 | |
Goodwill, ending balance | 361,427,000 | $ 358,736,000 |
Impairment of goodwill | $ 0 | $ 0 |
Balance Sheet Components - Sche
Balance Sheet Components - Schedule of Accrued Expenses and Other Liabilities (Details) - USD ($) $ in Thousands | Feb. 05, 2023 | Feb. 06, 2022 |
Balance Sheet Components Disclosure [Abstract] | ||
Taxes payable | $ 16,615 | $ 6,312 |
Accrued marketing | 14,228 | 13,257 |
Accrued cloud and outside services | 7,644 | 6,135 |
Supply chain-related accruals | 23,545 | 6,991 |
Accrued service logistics and professional services | 7,927 | 6,244 |
Acquisition earn-out and deferred consideration | 3,556 | 5,211 |
Finance lease liabilities, current | 5,432 | 1,035 |
Customer deposits from contracts with customers | 17,824 | 10,409 |
Other accrued liabilities | 26,978 | 22,917 |
Accrued expenses and other liabilities | $ 123,749 | $ 78,511 |
Deferred Revenue and Commissi_3
Deferred Revenue and Commissions - Deferred Commissions (Details) - USD ($) | 12 Months Ended | ||
Feb. 05, 2023 | Feb. 06, 2022 | Jan. 31, 2021 | |
Deferred Commissions [Roll Forward] | |||
Beginning balance | $ 246,307,000 | $ 187,924,000 | |
Additions | 155,414,000 | 217,595,000 | |
Recognition of deferred commissions | (155,865,000) | (159,212,000) | |
Ending balance | 245,856,000 | 246,307,000 | $ 187,924,000 |
Sales commission expenses | $ 170,000,000 | 175,900,000 | 150,200,000 |
Commission expected to be recognized over the next 12 months (percent) | 28% | ||
Impairment of capitalized commissions | $ 0 | $ 0 | $ 0 |
Deferred Revenue and Commissi_4
Deferred Revenue and Commissions - Deferred Revenue (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Feb. 05, 2023 | Feb. 06, 2022 | |
Contract Liability | ||
Additions | $ 155,414 | $ 217,595 |
Recognition of deferred commissions | (155,865) | (159,212) |
Revenue pertaining to deferred revenue recognized in period | 567,800 | 442,700 |
Product Revenue and Support Subscription Revenue | ||
Contract Liability | ||
Beginning balance | 1,079,872 | 843,697 |
Additions | 1,248,417 | 937,510 |
Recognition of deferred commissions | (942,639) | (701,335) |
Ending balance | $ 1,385,650 | $ 1,079,872 |
Deferred Revenue and Commissi_5
Deferred Revenue and Commissions - Remaining Performance Obligations (Details) $ in Billions | Feb. 05, 2023 USD ($) |
Revenue from Contract with Customer [Abstract] | |
Contracted but not recognized revenue | $ 1.8 |
Performance obligation expected to be recognized as revenue in the next 12 months (percent) | 47% |
Deferred Revenue and Commissi_6
Deferred Revenue and Commissions - Remaining Performance Obligation Period (Details) | Feb. 05, 2023 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-02-06 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue expected to be recognized term (in months) | 12 months |
Debt - Additional Information (
Debt - Additional Information (Details) | 1 Months Ended | 3 Months Ended | 12 Months Ended | ||||||
Aug. 24, 2020 USD ($) financial_ratio | Mar. 31, 2023 | Feb. 28, 2022 USD ($) | Apr. 30, 2018 USD ($) shares $ / shares | May 08, 2022 USD ($) | Feb. 05, 2023 USD ($) $ / shares | Feb. 06, 2022 USD ($) | Jan. 31, 2021 USD ($) | Apr. 04, 2018 $ / shares | |
Debt Instrument [Line Items] | |||||||||
Proceeds from issuance of convertible debt | $ 0 | $ 0 | $ 251,892,000 | ||||||
Closing price of stock (in dollars per share) | $ / shares | $ 29.91 | ||||||||
Revolving Credit Facility | |||||||||
Debt Instrument [Line Items] | |||||||||
Debt instrument, term | 5 years | ||||||||
Senior secured credit facility, maximum borrowing capacity | $ 300,000,000 | ||||||||
Credit facility, maturity period prior to stated maturity if out of compliance with liquidity threshold | 91 days | ||||||||
Credit facility, daily minimum sum of cash and cash equivalents and aggregate unused commitments to prevent maturity prior to stated maturity | $ 625,000,000 | ||||||||
Repayments of lines of credit | $ 250,000,000 | ||||||||
Interest rate during the period (percent) | 1.61% | 1.60% | 1.65% | ||||||
Interest expense | $ 300,000 | $ 4,100,000 | $ 1,400,000 | ||||||
Number of financial ratios | financial_ratio | 2 | ||||||||
Consolidated leverage ratio, maximum | 4.5 | ||||||||
Interest coverage ratio, minimum | 3 | ||||||||
Revolving Credit Facility | London Interbank Offered Rate (LIBOR) | Interest Rate Floor | |||||||||
Debt Instrument [Line Items] | |||||||||
Effective interest rate (percent) | 0% | ||||||||
Revolving Credit Facility | London Interbank Offered Rate (LIBOR) | Interest Rate Floor | Subsequent Event | |||||||||
Debt Instrument [Line Items] | |||||||||
Effective interest rate (percent) | 0% | ||||||||
Revolving Credit Facility | Minimum | |||||||||
Debt Instrument [Line Items] | |||||||||
Commitment fee (percent) | 0.25% | ||||||||
Revolving Credit Facility | Minimum | Base Rate | |||||||||
Debt Instrument [Line Items] | |||||||||
Margin rate (percent) | 0.50% | ||||||||
Revolving Credit Facility | Minimum | London Interbank Offered Rate (LIBOR) | |||||||||
Debt Instrument [Line Items] | |||||||||
Margin rate (percent) | 1.50% | ||||||||
Revolving Credit Facility | Minimum | London Interbank Offered Rate (LIBOR) | Subsequent Event | |||||||||
Debt Instrument [Line Items] | |||||||||
Margin rate (percent) | 1.50% | ||||||||
Revolving Credit Facility | Maximum | |||||||||
Debt Instrument [Line Items] | |||||||||
Commitment fee (percent) | 0.40% | ||||||||
Revolving Credit Facility | Maximum | Base Rate | |||||||||
Debt Instrument [Line Items] | |||||||||
Margin rate (percent) | 1.25% | ||||||||
Revolving Credit Facility | Maximum | London Interbank Offered Rate (LIBOR) | |||||||||
Debt Instrument [Line Items] | |||||||||
Margin rate (percent) | 2.25% | ||||||||
Revolving Credit Facility | Maximum | London Interbank Offered Rate (LIBOR) | Subsequent Event | |||||||||
Debt Instrument [Line Items] | |||||||||
Margin rate (percent) | 2.25% | ||||||||
Capped Call | |||||||||
Debt Instrument [Line Items] | |||||||||
Payment to enter into agreement | $ 64,600,000 | ||||||||
Common stock | |||||||||
Debt Instrument [Line Items] | |||||||||
Closing price of stock (in dollars per share) | $ / shares | $ 29.91 | ||||||||
Common stock | Capped Call | |||||||||
Debt Instrument [Line Items] | |||||||||
Exercise price (in dollars per share) | $ / shares | $ 39.66 | ||||||||
Exercise price premium percentage over last reported sales price | 100% | ||||||||
Convertible Senior Notes | |||||||||
Debt Instrument [Line Items] | |||||||||
Principal amount | $ 575,000,000 | ||||||||
Interest rate ( as a percent) | 0.125% | ||||||||
Proceeds from issuance of convertible debt | $ 562,100,000 | ||||||||
Conversion percentage of principal amount plus accrued and unpaid contingent interest | 100% | ||||||||
Convertible debt, fair value based on the closing trading price per $100 of the Notes | $ 660,000,000 | 681,800,000 | |||||||
If-converted value | $ 654,600,000 | ||||||||
Remaining term of the notes | 2 months | ||||||||
Interest expense | $ 3,314,000 | $ 31,697,000 | |||||||
Convertible Senior Notes | Common stock | |||||||||
Debt Instrument [Line Items] | |||||||||
Number of convertible shares at initial conversion rate (in shares) | shares | 21,884,155 | ||||||||
Conversion ratio (in shares per $1,000 principal amount) | 0.0380594 | ||||||||
Conversion price (in dollars per share) | $ / shares | $ 26.27 |
Debt - Convertible Debt (Detail
Debt - Convertible Debt (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Feb. 05, 2023 | Feb. 06, 2022 | |
Convertible Senior Notes | ||
Liability: | ||
Principal | $ 575,000 | $ 575,000 |
Less: debt discount, net of amortization | 0 | (35,641) |
Less: debt issuance costs, net of amortization | (494) | (2,580) |
Net carrying amount of the Notes | 574,506 | 536,779 |
Additional Paid-In Capital | ||
Stockholders' equity recorded at issuance: | ||
Allocated value of the conversion feature | 136,333 | |
Less: debt issuance costs | 0 | (3,068) |
Additional paid-in capital | $ 0 | $ 133,265 |
Debt - Interest Expense (Detail
Debt - Interest Expense (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Feb. 05, 2023 | Feb. 06, 2022 | Jan. 31, 2021 | |
Debt Instrument [Line Items] | |||
Total amortization of debt discount and debt issuance costs | $ 3,210 | $ 31,577 | $ 29,070 |
Convertible Senior Notes | |||
Debt Instrument [Line Items] | |||
Amortization of debt discount | 0 | 28,874 | |
Amortization of debt issuance costs | 2,598 | 2,091 | |
Total amortization of debt discount and debt issuance costs | 2,598 | 30,965 | |
Contractual interest expense | 716 | 732 | |
Total interest expense related to the Notes | $ 3,314 | $ 31,697 | |
Effective interest rate of the liability component ( as a percent) | 0.60% | 5.60% |
Commitments and Contingencies -
Commitments and Contingencies - (Details) - USD ($) | Feb. 05, 2023 | Feb. 06, 2022 |
Commitments and Contingencies Disclosure [Abstract] | ||
Non-cancelable purchase obligations | $ 445,000,000 | |
Outstanding letters of credit | 8,000,000 | $ 6,700,000 |
Loss contingency | $ 0 |
Leases - Additional Information
Leases - Additional Information (Details) - USD ($) $ in Thousands | 1 Months Ended | ||||
Jun. 30, 2022 | May 31, 2024 | Feb. 05, 2023 | Aug. 31, 2022 | Feb. 06, 2022 | |
Lessee, Lease, Description [Line Items] | |||||
Sublease term | 8 years | ||||
Total lease payments that include rent escalation and abatement clauses | $ 100,200 | $ 214,554 | $ 89,400 | ||
Weighted-average remaining lease term (in years) | 5 years 2 months 12 days | 4 years 6 months | |||
Weighted-average discount rate | 6.10% | 5.70% | |||
Forecast | |||||
Lessee, Lease, Description [Line Items] | |||||
Total lease payments that include rent escalation and abatement clauses | $ 10,800 |
Leases - Lease Costs (Details)
Leases - Lease Costs (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Feb. 05, 2023 | Feb. 06, 2022 | Jan. 31, 2021 | |
Leases [Abstract] | |||
Fixed operating lease cost | $ 47,533 | $ 37,598 | $ 37,411 |
Variable lease cost | 8,521 | 10,228 | 9,168 |
Short-term lease cost (12 months or less) | 3,787 | 4,178 | 5,734 |
Amortization of finance lease right-of-use assets | 3,028 | 384 | 0 |
Interest on finance lease liabilities | 330 | 42 | 0 |
Total finance lease cost | 3,358 | 426 | 0 |
Total lease cost | $ 63,199 | $ 52,430 | $ 52,313 |
Leases - Lease Term and Discoun
Leases - Lease Term and Discount Rate (Details) - USD ($) $ in Thousands | Feb. 05, 2023 | Feb. 06, 2022 |
Operating leases: | ||
Weighted-average remaining lease term (in years) | 5 years 2 months 12 days | 4 years 6 months |
Weighted-average discount rate | 6.10% | 5.70% |
Finance leases: | ||
Finance lease right-of-use assets, gross | $ 17,596 | $ 3,577 |
Accumulated amortization | (3,412) | (384) |
Finance lease right-of-use assets, net | 14,184 | 3,193 |
Finance lease liabilities, current | 5,432 | 1,035 |
Finance lease liabilities, non-current | 4,765 | 1,487 |
Total finance lease liabilities | $ 10,197 | $ 2,522 |
Weighted-average remaining lease term (in years) | 3 years 3 months 18 days | 3 years 7 months 6 days |
Weighted-average discount rate | 5.10% | 2.70% |
Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration] | Other liabilities, non-current, Accrued expenses and other liabilities | Other liabilities, non-current, Accrued expenses and other liabilities |
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] | Accrued expenses and other liabilities | Accrued expenses and other liabilities |
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] | Other liabilities, non-current | Other liabilities, non-current |
Leases - Supplemental Cash Flow
Leases - Supplemental Cash Flow Information Related to Leases (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Feb. 05, 2023 | Feb. 06, 2022 | |
Leases [Abstract] | ||
Operating cash outflows for operating leases | $ 49,955 | $ 36,648 |
Financing cash outflows for finance leases | 6,138 | 1,000 |
Operating leases | 80,962 | 7,517 |
Finance leases | $ 14,019 | $ 3,577 |
Leases - Future Lease Payments
Leases - Future Lease Payments Under Non-Cancelable Leases (Details) - USD ($) $ in Thousands | Feb. 05, 2023 | Aug. 31, 2022 | Jun. 30, 2022 | Feb. 06, 2022 |
Operating Leases | ||||
2024 | $ 45,153 | |||
2025 | 48,315 | |||
2026 | 36,366 | |||
2027 | 19,384 | |||
2028 | 21,062 | |||
Thereafter | 44,274 | |||
Total future lease payments | 214,554 | $ 89,400 | $ 100,200 | |
Less: imputed interest | (38,374) | |||
Present value of total lease liabilities | 176,180 | |||
Finance Leases | ||||
2024 | 5,839 | |||
2025 | 4,728 | |||
2026 | 183 | |||
2027 | 0 | |||
2028 | 0 | |||
Thereafter | 0 | |||
Total future lease payments | 10,750 | |||
Less: imputed interest | (553) | |||
Present value of total lease liabilities | $ 10,197 | $ 2,522 |
Restructuring and Other (Detail
Restructuring and Other (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Jan. 31, 2021 | Feb. 05, 2023 | |
Restructuring Cost and Reserve [Line Items] | ||
Lease liabilities | $ 176,180 | |
COVID-19 Pandemic Costs | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and other | $ 9,800 | |
COVID-19 Pandemic Costs | Restructuring Charges | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and other | 8,900 | |
COVID-19 Pandemic Costs | Cost of Revenue | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and other | 900 | |
Ceased Use of Certain Leased Facilities | ||
Restructuring Cost and Reserve [Line Items] | ||
Impairment charge | 7,500 | |
Lease liabilities | 2,400 | |
One-time Involuntary Termination Benefits | Restructuring Charges | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and other | $ 12,200 |
Stockholders' Equity - Addition
Stockholders' Equity - Additional Information (Details) | 2 Months Ended | 12 Months Ended | |||||
Mar. 31, 2023 USD ($) | Feb. 05, 2023 USD ($) stock_class $ / shares shares | Feb. 06, 2022 USD ($) $ / shares shares | Jan. 31, 2021 USD ($) $ / shares shares | Mar. 31, 2022 USD ($) | Feb. 28, 2021 USD ($) | Aug. 31, 2019 USD ($) | |
Class of Stock [Line Items] | |||||||
Preferred stock, shares authorized (in shares) | 20,000,000 | 20,000,000 | |||||
Preferred stock, shares issued (in shares) | 0 | 0 | |||||
Preferred stock, shares outstanding (in shares) | 0 | 0 | |||||
Number of classes of stock | stock_class | 2 | ||||||
Common stock, shares authorized (in shares) | 2,250,000,000 | 2,250,000,000 | |||||
Board of Directors | |||||||
Class of Stock [Line Items] | |||||||
Value approved for repurchase | $ | $ 250,000,000 | ||||||
Remaining authorized repurchase amount | $ | $ 31,100,000 | ||||||
Board of Directors | Subsequent Event | |||||||
Class of Stock [Line Items] | |||||||
Additional value approved for repurchase | $ | $ 250,000,000 | ||||||
Class A common stock | |||||||
Class of Stock [Line Items] | |||||||
Common stock, shares authorized (in shares) | 2,000,000,000 | 2,000,000,000 | |||||
Common stock, par value per share (in dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 | |||||
Common stock, shares issued (in shares) | 304,076,234 | 292,633,000 | |||||
Common stock, shares outstanding (in shares) | 304,076,234 | 292,633,000 | |||||
Stock repurchased and retired (in shares) | 7,832,229 | 8,489,168 | 9,526,556 | ||||
Stock repurchased and retired, average cost (in dollars per share) | $ / shares | $ 27.95 | $ 23.56 | $ 14.17 | ||||
Stock repurchased and retired, value | $ | $ 218,900,000 | $ 200,000,000 | $ 135,000,000 | ||||
Class A common stock | Subsequent Event | |||||||
Class of Stock [Line Items] | |||||||
Stock repurchased and retired, value | $ | $ 31,100,000 | ||||||
Class A common stock | Board of Directors | |||||||
Class of Stock [Line Items] | |||||||
Value approved for repurchase | $ | $ 200,000,000 | $ 150,000,000 | |||||
Class B common stock | |||||||
Class of Stock [Line Items] | |||||||
Common stock, shares authorized (in shares) | 250,000,000 | 250,000,000 | |||||
Common stock, par value per share (in dollars per share) | $ / shares | $ 0.0001 | $ 0.0001 |
Stockholders' Equity - Summary
Stockholders' Equity - Summary of Reserved Shares of Common Stock for Future Issuance (Details) - shares | Feb. 05, 2023 | Feb. 06, 2022 |
Class of Stock [Line Items] | ||
Shares underlying outstanding equity awards (in shares) | 9,268,498 | 12,268,938 |
Shares reserved for future equity awards (in shares) | 62,000,412 | |
Employee stock purchase plan | ||
Class of Stock [Line Items] | ||
Shares reserved for future equity awards (in shares) | 5,309,812 | |
Unvested RSUs and PRSUs | ||
Class of Stock [Line Items] | ||
Shares underlying outstanding equity awards (in shares) | 26,760,520 | |
Employee Stock Options | ||
Class of Stock [Line Items] | ||
Shares reserved for future equity awards (in shares) | 20,661,582 |
Equity Incentive Plans - Additi
Equity Incentive Plans - Additional Information (Details) | 12 Months Ended | |||
Feb. 05, 2023 USD ($) period plan $ / shares shares | Feb. 06, 2022 USD ($) | Jan. 31, 2021 USD ($) shares | Jan. 31, 2016 shares | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Number of equity incentive plans | plan | 2 | |||
Shares reserved for future equity awards (in shares) | shares | 62,000,412 | |||
Total stock-based compensation expense | $ 327,617,000 | $ 286,963,000 | $ 242,344,000 | |
Closing price of stock (in dollars per share) | $ / shares | $ 29.91 | |||
Stock options to purchase common stock | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Shares reserved for future equity awards (in shares) | shares | 20,661,582 | |||
Total stock-based compensation expense | $ 4,900,000 | 7,700,000 | 8,600,000 | |
Unrecognized compensation cost related to stock awards, weighted-average period | 1 year 1 month 6 days | |||
Intrinsic value of exercised options | $ 63,500,000 | 105,100,000 | 118,800,000 | |
Total grant date fair value of options vested | 7,000,000 | $ 16,500,000 | $ 20,100,000 | |
Unrecognized compensation cost | $ 2,400,000 | |||
Dividend rate | 0% | |||
Employee Stock Purchase Plan | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Dividend rate | 0% | 0% | 0% | |
Performance Restricted Stock Units (PRSUs) | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Granted (in shares) | shares | 1,147,187 | |||
Award vesting rights, percentage | 100% | |||
Earned (in shares) | shares | 1,770,282 | |||
Unvested RSUs and PRSUs | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Total stock-based compensation expense | $ 299,700,000 | $ 242,100,000 | $ 199,100,000 | |
Unrecognized compensation cost related to stock awards, weighted-average period | 2 years 8 months 12 days | |||
Granted (in shares) | shares | 15,319,768 | |||
Aggregate fair value of awards vested during the period | $ 402,700,000 | 322,200,000 | 183,400,000 | |
Unrecognized employee compensation cost | 588,400,000 | |||
Unvested restricted stock | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Total stock-based compensation expense | 0 | 1,800,000 | 9,300,000 | |
Aggregate fair value of awards vested during the period | $ 1,900,000 | 10,400,000 | $ 18,300,000 | |
Minimum | Performance Restricted Stock Units (PRSUs) | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Award vesting rights, percentage | 0% | |||
Maximum | Performance Restricted Stock Units (PRSUs) | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Award vesting rights, percentage | 150% | |||
Common stock | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Closing price of stock (in dollars per share) | $ / shares | $ 29.91 | |||
2015 Equity Incentive Plan | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Equity awards of vest expire period | 10 years | |||
2015 Equity Incentive Plan | Minimum | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Equity awards vesting period | 2 years | |||
2015 Equity Incentive Plan | Maximum | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Equity awards vesting period | 4 years | |||
2015 Equity Incentive Plan | Common stock | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Shares initially reserved for issuance (in shares) | shares | 27,000,000 | |||
Equity incentive plan, period in force | 10 years | |||
Increase in shares reserved by percentage of capital stock | 5% | |||
2015 Employee Stock Purchase Plan | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Shares reserved for future equity awards (in shares) | shares | 5,000,000 | |||
Employee stock purchase plan offering period | 24 months | |||
Number of purchase periods | period | 4 | |||
Purchase period, term | 6 months | |||
ESPP modification charge | $ 10,400,000 | 0 | $ 23,800,000 | |
Total stock-based compensation expense | 22,900,000 | 35,400,000 | $ 25,800,000 | |
Unrecognized stock-based compensation expense | $ 31,500,000 | |||
Unrecognized compensation cost related to stock awards, weighted-average period | 1 year 7 months 6 days | |||
2015 Employee Stock Purchase Plan | Common stock | ||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
Increase in shares reserved by percentage of capital stock | 1% | |||
Shares reserved for future equity awards (in shares) | shares | 3,500,000 | |||
Maximum annual increase to shares reserved for issuance under the Plan | shares | 3,500,000 | |||
Payroll deductions percentage | 30% | |||
Share cap for ESPP at purchase date (in shares) | shares | 3,000 | |||
Dollar cap per purchase period | $ 7,500 | |||
Calendar year gap for ESPP contribution amount | $ 25,000 | |||
Purchase price as percentage of fair market value of common stock | 85% |
Equity Incentive Plans - Equity
Equity Incentive Plans - Equity Incentive Plans (Details) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | |
Feb. 05, 2023 | Feb. 06, 2022 | |
Options Outstanding, Number of Shares | ||
Beginning balance (in shares) | 12,268,938 | |
Options exercised (in shares) | (2,988,068) | |
Options forfeited (in shares) | (12,372) | |
Ending balance (in shares) | 9,268,498 | 12,268,938 |
Vested and exercisable (in shares) | 9,077,014 | |
Options Outstanding, Weighted- Average Exercise Price | ||
Beginning balance (in dollars per share) | $ 10.25 | |
Options exercised (in dollars per share) | 8.29 | |
Options forfeited (in dollars per share) | 1.83 | |
Ending balance (in dollars per share) | 10.90 | $ 10.25 |
Vested and exercisable (in dollars per share) | $ 11.04 | |
Weighted- Average Remaining Contractual Life (Years) | ||
Weighted Average Remaining Contractual Life (Years) | 2 years 8 months 12 days | 3 years 6 months |
Weighted Average Remaining Contractual Life (Years), Vested and exercisable | 2 years 7 months 6 days | |
Aggregate Intrinsic Value (in thousands) | ||
Aggregate Intrinsic Value | $ 176,674 | $ 198,266 |
Aggregate Intrinsic Value, Vested and exercisable | $ 171,315 |
Equity Incentive Plans - Summar
Equity Incentive Plans - Summary of Estimate Fair Values (Details) - $ / shares | 12 Months Ended | ||
Feb. 05, 2023 | Feb. 06, 2022 | Jan. 31, 2021 | |
Employee Stock Options | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Expected term (in years) | 5 years 7 months 24 days | ||
Expected volatility | 52.07% | ||
Risk-free interest rate | 0.30% | ||
Dividend rate | 0% | ||
Fair value of common stock (in dollars per share) | $ 15.79 | ||
Employee Stock Purchase Plan | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Dividend rate | 0% | 0% | 0% |
Expected volatility, minimum | 45% | 44% | 52% |
Expected volatility, maximum | 54% | 61% | 113% |
Risk-free interest rate, minimum | 0.90% | 0.10% | 0.10% |
Risk-free interest rate, maximum | 4% | 0.20% | 0.40% |
Employee Stock Purchase Plan | Minimum | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Expected term (in years) | 6 months | 6 months | 6 months |
Fair value of common stock (in dollars per share) | $ 28.73 | $ 23.63 | $ 9.07 |
Employee Stock Purchase Plan | Maximum | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Expected term (in years) | 2 years | 2 years | 2 years |
Fair value of common stock (in dollars per share) | $ 31.68 | $ 26.69 | $ 15.26 |
Equity Incentive Plans - Restri
Equity Incentive Plans - Restricted Stock Units (Details) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | |
Feb. 05, 2023 | Feb. 06, 2022 | |
Unvested RSUs and PRSUs | ||
Number of RSUs and PRSUs Outstanding | ||
Unvested, beginning balance (in shares) | 28,712,878 | |
Granted (in shares) | 15,319,768 | |
Vested (in shares) | (13,915,802) | |
Forfeited (in shares) | (3,356,324) | |
Unvested, ending balance (in shares) | 26,760,520 | |
Weighted-Average Grant Date Fair Value | ||
Unvested, beginning balance (in dollars per share) | $ 19.53 | |
Granted (in dollars per share) | 29.67 | |
Vested (in dollars per share) | 20.05 | |
Forfeited (in dollars per share) | 21.75 | |
Unvested, ending balance (in dollars per share) | $ 24.78 | |
Aggregate Intrinsic Value (in thousands) | $ 800,407 | $ 757,446 |
Unvested restricted stock | ||
Number of RSUs and PRSUs Outstanding | ||
Unvested, beginning balance (in shares) | 54,977 | |
Vested (in shares) | (54,977) | |
Forfeited (in shares) | 0 | |
Unvested, ending balance (in shares) | 0 | |
Weighted-Average Grant Date Fair Value | ||
Unvested, beginning balance (in dollars per share) | $ 20.02 | |
Vested (in dollars per share) | 20.02 | |
Forfeited (in dollars per share) | 0 | |
Unvested, ending balance (in dollars per share) | $ 0 | |
Aggregate Intrinsic Value (in thousands) | $ 0 | $ 1,450 |
Equity Incentive Plans - Summ_2
Equity Incentive Plans - Summary of Stock-Based Compensation Expenses (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Feb. 05, 2023 | Feb. 06, 2022 | Jan. 31, 2021 | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Total stock-based compensation expense | $ 327,617 | $ 286,963 | $ 242,344 |
Cost of revenue—product | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Total stock-based compensation expense | 10,245 | 6,334 | 4,001 |
Cost of revenue—subscription services | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Total stock-based compensation expense | 22,630 | 21,240 | 14,979 |
Research and development | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Total stock-based compensation expense | 161,694 | 142,264 | 117,220 |
Sales and marketing | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Total stock-based compensation expense | 72,507 | 71,439 | 65,248 |
General and administrative | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Total stock-based compensation expense | $ 60,541 | $ 45,686 | $ 40,896 |
Net Income (Loss) per Share A_3
Net Income (Loss) per Share Attributable to Common Stockholders - Net Income (Loss) per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 12 Months Ended | ||
Feb. 05, 2023 | Feb. 06, 2022 | Jan. 31, 2021 | |
Earnings Per Share [Abstract] | |||
Net income (loss) attributable to common stockholders, basic | $ 73,071 | $ (143,259) | $ (282,076) |
Add: Interest charges related to our Notes | 3,314 | 0 | 0 |
Net income (loss) attributable to common stockholders, diluted | $ 76,385 | $ (143,259) | $ (282,076) |
Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, basic (in shares) | 299,478 | 285,882 | 267,824 |
Add: Dilutive effect of common stock equivalents (in shares) | 39,706 | 0 | 0 |
Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, diluted (in shares) | 339,184 | 285,882 | 267,824 |
Net income (loss) per share attributable to common stockholders, basic (in dollars per share) | $ 0.24 | $ (0.50) | $ (1.05) |
Net income (loss) per share attributable to common stockholders, diluted (in dollars per share) | $ 0.23 | $ (0.50) | $ (1.05) |
Net Income (Loss) per Share A_4
Net Income (Loss) per Share Attributable to Common Stockholders - Shares Excluded (Details) - shares shares in Thousands | 12 Months Ended | ||
Feb. 05, 2023 | Feb. 06, 2022 | Jan. 31, 2021 | |
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | |||
Anti-dilutive securities excluded from computation of earnings per share, amount (in shares) | 41,187 | 72,440 | 80,337 |
Stock options to purchase common stock | |||
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | |||
Anti-dilutive securities excluded from computation of earnings per share, amount (in shares) | 10,516 | 15,686 | 23,180 |
Unvested RSUs and PRSUs | |||
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | |||
Anti-dilutive securities excluded from computation of earnings per share, amount (in shares) | 29,780 | 32,491 | 31,980 |
Unvested restricted stock | |||
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | |||
Anti-dilutive securities excluded from computation of earnings per share, amount (in shares) | 6 | 257 | 1,145 |
Shares related to convertible senior notes | |||
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | |||
Anti-dilutive securities excluded from computation of earnings per share, amount (in shares) | 0 | 21,884 | 21,884 |
Shares issuable pursuant to the ESPP | |||
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | |||
Anti-dilutive securities excluded from computation of earnings per share, amount (in shares) | 885 | 2,122 | 2,148 |
Other Income (Expense), Net (De
Other Income (Expense), Net (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Feb. 05, 2023 | Feb. 06, 2022 | Jan. 31, 2021 | |
Other Income and Expenses [Abstract] | |||
Interest income | $ 17,320 | $ 9,371 | $ 17,442 |
Interest expense | (4,749) | (36,677) | (31,403) |
Foreign currency transactions gains (losses) | (8,345) | (5,235) | 2,507 |
Other income | 4,069 | 2,443 | 2,327 |
Total other income (expense), net | $ 8,295 | $ (30,098) | $ (9,127) |
Income Taxes - Schedule of Geog
Income Taxes - Schedule of Geographical Breakdown of Income (Loss) before Provision for Income Taxes (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Feb. 05, 2023 | Feb. 06, 2022 | Jan. 31, 2021 | |
Income Tax Disclosure [Abstract] | |||
Domestic | $ 39,004 | $ (192,058) | $ (312,119) |
International | 52,804 | 63,562 | 41,959 |
Income (loss) before provision for income taxes | $ 91,808 | $ (128,496) | $ (270,160) |
Income Taxes - Components of Pr
Income Taxes - Components of Provision for Income Taxes (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Feb. 05, 2023 | Feb. 06, 2022 | Jan. 31, 2021 | |
Current: | |||
State | $ 5,999 | $ 592 | $ 442 |
Foreign | 12,020 | 12,525 | 8,006 |
Total | 18,019 | 13,117 | 8,448 |
Deferred: | |||
Federal | (639) | 0 | (218) |
State | (99) | 0 | 0 |
Foreign | 1,456 | 1,646 | 3,686 |
Total | 718 | 1,646 | 3,468 |
Provision for income taxes | $ 18,737 | $ 14,763 | $ 11,916 |
Income Taxes - Reconciliation o
Income Taxes - Reconciliation of the Federal Statutory Income Tax Rate and Effective Income Tax Rate (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Feb. 05, 2023 | Feb. 06, 2022 | Jan. 31, 2021 | |
Income Tax Disclosure [Abstract] | |||
Tax at federal statutory rate | $ 19,280 | $ (26,984) | $ (56,734) |
State tax, net of federal benefit | 4,625 | 468 | 349 |
Stock-based compensation expense | (11,976) | (19,658) | (604) |
Research and development tax credits | (26,634) | (16,783) | (14,138) |
U.S. taxes on foreign income | 19,065 | 25,059 | 14,021 |
Foreign rate differential | (425) | (1,698) | 2,282 |
Withholding tax | 2,339 | 143 | 34 |
Change in valuation allowance | 10,631 | 48,270 | 63,146 |
Non-deductible expenses | 2,091 | 4,381 | 0 |
Other | (259) | 1,565 | 3,560 |
Provision for income taxes | $ 18,737 | $ 14,763 | $ 11,916 |
Income Taxes - Schedule of Defe
Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands | Feb. 05, 2023 | Feb. 06, 2022 |
Deferred tax assets: | ||
Net operating loss carryforwards | $ 198,495 | $ 369,904 |
Tax credit carryover | 171,775 | 134,085 |
Accruals and reserves | 34,506 | 22,625 |
Deferred revenue | 87,026 | 66,242 |
Stock-based compensation expense | 25,564 | 25,247 |
ASC 842 lease liabilities | 40,772 | 28,577 |
Capitalized research and development | 154,027 | 0 |
Other | 4,950 | 1,879 |
Total deferred tax assets | 717,115 | 648,559 |
Valuation allowance | (598,997) | (554,553) |
Total deferred tax assets, net of valuation allowance | 118,118 | 94,006 |
Deferred tax liabilities: | ||
Depreciation and amortization | (31,744) | (12,992) |
Deferred commissions | (53,421) | (53,219) |
Convertible debt | 0 | (4,642) |
ASC 842 right-of-use assets | (36,366) | (24,608) |
Acquired intangibles and goodwill | (4,702) | (6,850) |
Interest income | (2,521) | (874) |
Total deferred tax liabilities | (128,754) | (103,185) |
Net deferred tax liabilities | $ (10,636) | $ (9,179) |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Details) - USD ($) | 12 Months Ended | |||
Feb. 05, 2023 | Feb. 06, 2022 | Jan. 31, 2021 | Feb. 02, 2020 | |
Operating Loss Carryforwards [Line Items] | ||||
Undistributed earnings of foreign subsidiaries | $ 176,200,000 | |||
Deferred tax assets, increase (decrease) in valuation allowance | 44,400,000 | $ 70,100,000 | ||
Gross unrecognized tax benefit | 68,897,000 | $ 51,582,000 | $ 39,571,000 | $ 28,570,000 |
Unrecognized tax benefits that would impact effective tax rate | 6,200,000 | |||
Current or cumulative interest and penalties related to uncertain tax positions | 0 | |||
Federal | ||||
Operating Loss Carryforwards [Line Items] | ||||
Net operating loss carryforwards | 795,100,000 | |||
Research and development tax credit carryforwards | 134,200,000 | |||
State | ||||
Operating Loss Carryforwards [Line Items] | ||||
Net operating loss carryforwards | 578,000,000 | |||
Research and development tax credit carryforwards | $ 116,000,000 |
Income Taxes - Activity Related
Income Taxes - Activity Related to Unrecognized Tax Benefits (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Feb. 05, 2023 | Feb. 06, 2022 | Jan. 31, 2021 | |
Reconciliation of Unrecognized Tax Benefits | |||
Gross unrecognized tax benefits—beginning balance | $ 51,582 | $ 39,571 | $ 28,570 |
Decreases related to tax positions taken during prior years | 0 | (173) | (345) |
Increases related to tax positions taken during prior years | 2,172 | 1,201 | 1,881 |
Increases related to tax positions taken during current year | 15,143 | 10,983 | 9,465 |
Gross unrecognized tax benefits—ending balance | $ 68,897 | $ 51,582 | $ 39,571 |
Segment Information - Revenue b
Segment Information - Revenue by Geographic Area (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Feb. 05, 2023 | Feb. 06, 2022 | Jan. 31, 2021 | |
Revenues From External Customers And Long Lived Assets [Line Items] | |||
Total revenue | $ 2,753,434 | $ 2,180,848 | $ 1,684,179 |
United States | |||
Revenues From External Customers And Long Lived Assets [Line Items] | |||
Total revenue | 1,971,757 | 1,580,022 | 1,195,428 |
Rest of the world | |||
Revenues From External Customers And Long Lived Assets [Line Items] | |||
Total revenue | $ 781,677 | $ 600,826 | $ 488,751 |
Segment Information - Long-Live
Segment Information - Long-Lived Assets by Geographic Area (Details) - USD ($) $ in Thousands | Feb. 05, 2023 | Feb. 06, 2022 |
Revenues From External Customers And Long Lived Assets [Line Items] | ||
Property and equipment, net | $ 272,445 | $ 195,282 |
United States | ||
Revenues From External Customers And Long Lived Assets [Line Items] | ||
Property and equipment, net | 259,131 | 187,228 |
Rest of the world | ||
Revenues From External Customers And Long Lived Assets [Line Items] | ||
Property and equipment, net | $ 13,314 | $ 8,054 |
401(k) Plan - Additional Inform
401(k) Plan - Additional Information (Details) - USD ($) | 12 Months Ended | ||
Feb. 05, 2023 | Feb. 06, 2022 | Jan. 31, 2021 | |
Compensation Related Costs [Abstract] | |||
Maximum annual contributions per employee (as a percent) | 85% | ||
Company match of employee contributions (percent) | 50% | ||
Maximum annual employer contribution, per employee | $ 4,000 | ||
Company contributions to the plan | $ 12,200,000 | $ 11,100,000 | $ 10,200,000 |